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Skin is the largest organ in the body that protects the organism from 
environmental,  chemical  and  physical  traumas  of  each  passing  day. 
The  protective  skin  epidermal  permeability  barrier  (EPB)  is  formed 
within the exterior layers of the epidermis, which are regularly sloughed 
off  and  repopulated  by  movement  of  inner  cells.  The  epidermal 
permeability  barrier  is  established  during  in  utero  development  and 
maintained through lifetime. Impaired epidermal barrier formation is one    
of  the  major  features  of  several  dermatoses  such  as  psoriasis  and 
atopic dermatitis. 
 
Chicken ovalbumin upstream promoter transcription factor (COUP-TF)-
interacting protein 2 (Ctip2), also known as Bcl11b, is a C2H2 zinc finger 
protein expressed in many organs and tissues. It has been shown to 
regulate the development of thymocyte, tooth and corticospinal motor 
neurons.  Ctip2  is  highly  expressed  in  mouse  epidermis  during  skin 
organogenesis and in adulthood. It is crucial for epidermal homeostasis 
and  protective  barrier  formation  in  developing  mouse  embryos. 
Germline (Ctip2- null mice) and selective ablation of Ctip2 in mouse 
epidermis (Ctip2
ep-/- mice) leads to increased transepidermal water loss  
(TEWL), impaired epidermal proliferation and terminal differentiation as 
well  as  altered  lipid  distribution  during  embryogenesis.  Sphingolipids 
account  for  ~50%  of  total  skin  lipids  by  weight  and  are  crucial 
components of epidermal barrier. We have recently identified Ctip2 as a 
key  regulator  of  skin  lipid  metabolism.  Germline  deletion  of  Ctip2  in 
mouse  embryos  leads  to  altered  lipid  composition  in  the  developing 
mouse epidermis by modulating the expression levels of key enzymes 
involved  in  lipid  metabolism  (bio-synthesis  and  catabolism).  We  also 
demonstrated that Ctip2 is recruited to the promoter regions of several    
genes  involved  in  the  ceramide  and  sphingomyelin  biosynthesis 
pathways and could directly regulate their expression. Thus, we have 
identified Ctip2 as a key regulator of several lipid metabolizing genes 
and  hence  epidermal  sphingolipid  biosynthesis  during  skin 
development. 
 
To study the role of Ctip2 in adult skin homeostasis, we have utilized 
Ctip2
ep-/- mouse model in which Ctip2 is selectively deleted in epidermal 
keratinocytes. We showed that keratinocytic ablation of Ctip2 leads to 
atopic dermatitis (AD)-like skin inflammation, characterized by alopecia, 
pruritus and scaling, as well as high infiltration of T lymphocytes and 
immune cells. We have also observed increased expression of Th2-
type cytokines and chemokines in the mutant skin, as well as systemic 
immune  responses  that  share  similarity  with  human  AD  patients. 
Furthermore, we discovered that thymic stromal lymphopoietin (TSLP) 
expression is significantly upregulated in the mutant epidermis as early 
as postnatal day 1 and Ctip2 was recruited to the promoter region of the 
TSLP gene in mouse epidermal keratinocytes.  The results suggest that 
upregulation of TSLP expression in the Ctip2
ep-/- epidermis could be due 
to a derepression of gene transcription in absence of Ctip2. Thus, our 
data  demonstrated  a  cell-autonomous  role  of  Ctip2  in  barrier    
maintenance  and  epidermal  homeostasis  in  adult  skin,  as  well  as  a 
non-cell  autonomous  role  of  keratinocytic  Ctip2  in  suppressing  skin 
inflammatory  responses  by  regulating  the  expression  of  Th2-type 
cytokines in adult mouse skin.  Present results establish an initiating 
role  of  epidermal  TSLP  in  AD  pathogenesis  via  a  novel  repressive 
regulatory  mechanism  mediated  by  Ctip2  in  mouse  epidermal 
keratinocytes. 
 
Altogether, our study indicates that Ctip2 could be involved in a diverse 
range  of  biological  events  in  skin  including  barrier  formation, 
maintenance and epidermal homeostasis. Ctip2 appears to be a master 
regulator in skin barrier functions by directly regulating the transcription 
of  a  subset  of  genes  involved  in  lipid  metabolism  and  inflammatory 
responses. 
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Chapter 1                                                                                      
General Introduction  
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1.1 Skin homeostasis and human health 
1.1.1 The structure and morphogenesis of mammalian skin  
Skin is the largest organ in the body that protects the organism from 
environmental,  chemical  and  physical  traumas  of  each  passing  day 
(Lippens  et  al.,  2009).  Skin  is  composed  of  epidermis  and  dermis, 
which are separated by a basement membrane of extracellular matrix 
(Fuchs and Raghavan, 2002).  The epidermis is a stratified epithelium 
that forms the uppermost compartment of the skin and is composed of 
four layers: basal, spinous, granular and stratum corneum (Fuchs and 
Raghavan, 2002). Keratinocytes are the most abundant cell type in the 
epidermis, that move from proliferative cells in the basal layer through 
the granular layer to form cornified envelope, finally to stratum corneum 
as flattened, dead cells (Candi et al., 2005) (Figure 1.1).   
The  mouse  epidermis  develops  from  a  single‐layered  multipotent 
embryonic ectoderm, which is highly proliferative (Mack et al., 2005). 
Skin  proliferation  markers  keratin  5  (K5)  and  keratin  14  (K14) 
expressions  were  observed  as  early  as  embryonic  day  9.5  (E9.5), 
facilitating  the  stratification  events  that  lead  to  the  formation  of  the 
periderm  (E9‐E12),  which  overlies  the  ectoderm  (Byrne  et  al.,  2003; 
Mack  et  al.,  2005).  After  a  series  of  proliferation  and  terminal 
differentiation events, the epidermis is fully formed by E18.5, consisting  
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of three live morphologically distinct living layers (basal, spinous, and 
granular) and a dead (cornified) layer (Byrne et al., 2003; Mack et al., 
2005) (Figure 1.1).  
 
1.1.2 Skin permeability barrier formation 
Barrier  function  is  mainly  conferred  by  the  outermost  layer  of  the 
epidermis, the stratum corneum (Hardman et al., 1998). The process of 
terminal differentiation starts when basal cells withdraw from the cell 
cycle and detach from the basement membrane. In the spinous layer, 
the cells are reinforced by a cytoskeletal framework of keratin filaments. 
Lamellar bodies in the granular layer are the reservoir of lipids. Keratins 
bundled  with  macrofibrils  though  filaggrin,  and  cornified  envelopes 
(CEs)  are  assembled  by  precursor  proteins  underneath  plasma 
membranes such as transglutaminase (TGM). As the cell membrane 
disintegrates,  transglutaminase  crosslink  the  CE  proteins  irreversibly, 
creating  tough  insoluble  sac  surrounding  the  keratin  fibers.    Finally, 
lipids are extruded onto the CE scaffold and the epidermal permeability 
barrier is formed (Segre, 2006). Once built, this barrier has a “brick and 
mortar” structure, with keratin macrofibrils and CEs as bricks and the 
lipids as the mortar to seal together the CEs (Elias, 1983; Nemes and 
Steinert, 1999) (Figure 1.1).  
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1.1.3 Lipids in epidermal permeability barrier 
The exterior layer of skin, the stratum corneum (SC), plays a critical role 
in skin permeability barrier formation and maintenance. Mammalian SC 
contains a large number of lipids, such as ceramides, sphingomyelins, 
cholesterols and fatty acids (Elias and Menon, 1991; Ishikawa et al., 
2010). Ceramides (CERs) are the most abundant lipid types in the SC 
(50% by weight) and can be divided into at least 11 species (Oda et al., 
2008; Ishikawa et al., 2010). It has been shown that reduced content of 
CERs  leads  to  epidermal  water  loss  as  well  as  skin  epidermal 
dysfunctions,  and  causes  diseases  such  as  atopic  dermatitis  (AD) 
(Imokawa,  2009;  Ishikawa  et  al.,  2010).  Spingomyelins  are  another 
large group of epidermal sphingolipids, which have been reported as 
precursors  of  ceramides  (Schmuth  et  al.,  2000;  Uchida  et  al.,  2000; 
Holleran et al., 2006). Cholesterols and fatty acids are also major skin 
lipids, while cholesterol 3-sulfate (CSO4) is a ubiquitous metabolite of 
cholesterol,  which  is  involved  in  cornified  envelope  formation  by 
interacting with transglutaminase1 (Nemes et al., 2000). A large variety 
of skin fatty acids are synthesized in epidermis, and disruption of the 
skin permeability barrier leads to a rapid and marked increase in fatty 
acid synthesis by upregulating the activity and mRNA levels of several 
key enzymes involved in fatty acid biosynthesis (Feingold, 2007, 2009).  
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Furthermore,  following  acute  barrier  disruption,  the  recovery  of 
permeability barrier function is delayed, correlating with reduced fatty 
acid synthesis (Feingold, 2007). Moreover, the elongation of fatty acids 
is also critical as mice deficient in elongation of very-long-chain fatty 
acid-like 4 (Elovl4) have a severely disrupted permeability barrier and 
die perinatally (Cameron et al., 2007; Li et al., 2007; Vasireddy et al., 
2007). 
 
1.1.4 Impaired barrier and skin inflammatory disorders 
The  epidermal  permeability  barrier  is  established  during  in  utero 
development  and  maintained  throughout  the  lifetime.  Impaired 
epidermal barrier is one of the major features of several dermatoses 
such  as  psoriasis  and  atopic  dermatitis,  which  are  two  of  the  most 
common  inflammatory  skin  disorders  (Ghadially  et  al.,  1996;  Segre, 
2006). 
Psoriasis  is  a  chronic  inflammatory  skin  disease  that  shows  distinct 
erythrosquamous silvery scaly skin either in the areas of inflection or 
the entire body (Segre, 2006). Psoriasis has a 2%-3% of prevalence in 
western  populations,  affecting  mostly  adults.  1TPSJBUJD TLJO JT
DIBSBDUFSJ[FE CZ JOGMBNNBUJPO IZQFSQSPMJGFSBUJPO BOE BCOPSNBM 
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EJGGFSFOUJBUJPO 1TPSJBTJT XBT JOJUJBMMZ JEFOUJGJFE BT B 5IEFQFOEFOU
EJTFBTFEVFUPUIFPCTFSWBUJPOPG5IFMQFSUZQF	5I
DFMMTFDSFUFE
DZUPLJOFT TVDI BT JOUFSMFVLJO 	*-
 UVNPS OFDSPTJT GBDUPS BMQIB
	5/'α
 BOE JOUFSGFSPO HBNNB 	*/'(
 	(VEKPOTTPO FU BM 

)PXFWFS TUVEJFT QFSGPSNFE JO QTPSJBUJD MFTJPOT IBWF BMTP JEFOUJGJFE
DZUPLJOFT TVDI BT *- BOE *- UIBU BSF QSPEVDFE CZ 5I DFMMT
	3PCFSTPOBOE#PXDPDL
The causes of psoriasis have not yet 
been  fully  understood;  however,  genes  involved  in  skin  barrier 
formation such as loricrin (LOR), involucrin (IVL), the small proline rich 
proteins  (SPRRs)  and  late  cornified  envelope  proteins  (LCEs)  were 
altered in the skin of psoriasis patients, indicating a correlation between 
psoriasis and skin barrier defects (Roberson and Bowcock, 2010).10%-
30%  of  psoriasis  patients  develop  psoriatic  arthritis,  which  causes 
destruction of joints if not treated aggressively (Nograles et al., 2009). 
Psoriasis also increases the risk of heart diseases and stroke (Gelfand 
et al., 2006, 2009).  
Atopic  dermatitis  (AD)  is  a  chronic,  genetically  predisposed  skin 
inflammatory disease that starts at early childhood with a prevalence of 
10%-20%  in  children  and  1%-3%  in  adults  (Elias  and  Menon,  1991; 
Ishikawa  et  al.,  2010).  Clinical  features  of  AD  include  skin  xerosis,  
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pruritus and eczematoid skin lesion (Leung and Bieber, 2003). AD is 
characterized  by  both  skin  barrier  deficiencies  and  immunological 
responses  (Scharschmidt  and  Segre,  2008).  In  AD,  a  defective  skin 
barrier is thought to permit the penetration of allergens and induces the 
interactions  of  the  allergens  with  immune  cells,  promoting  the 
subsequent release of pro-inflammatory cytokines and chemokines and 
elevation  of  IgE  level  (Cork  et  al.,  2009).  The  molecular  pathways 
involved  in  AD  pathogenesis  remain  unclear.  Distinct  from  psoriasis, 
there  have  been  many  reports  on  the  connections  between  atopic 
dermatitis and Th2 inflammatory pathways. Pro-Th2 cytokines such as 
IL-4, IL-13, IL-5, and IL10 are elevated in AD patients (B. Brandt and 
Sivaprasad, 2011). One possible candidate that initiates inflammatory 
responses in AD is thymic stromal lymphopoietin (TSLP), which is a 
member of hematopoietic cytokine family and highly expressed in skin-
derived  epithelial  cells  and  also  in  fibroblasts  and  dendritic  cells 
(Comeau  and  Ziegler,  2010;  Ziegler,  2010;  De  Monte  et  al.,  2011; 
Kashyap et al., 2011; Yamada et al., 2012). TSLP signals through a 
heterodimeric receptor formed by TSLP receptor (TSLPR) as well as IL-
7 receptor alpha (IL7Ra) (Comeau and Ziegler, 2010). TSLP is a key 
keratinocyte-derived cytokine, whose expression was greatly increased 
in  the  epidermis  of  a  group  of  acute  and  chronic  atopic  dermatitis  
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patients  (Soumelis  et  al.,  2002).  In  mouse  models  with  skin  barrier 
deficiencies, mutation of genes (e.g. RXRα, VDR or Notch1) that are 
involved in barrier functions also leads to TSLP induction, subsequently 
causing  AD-like  phenotypes  (Li,  2005,  2006;  Demehri  et  al.,  2008; 
Ziegler, 2010). 
 
1.2 COUP-TF interacting proteins  
1.2.1 Nuclear receptors (NRs) 
Nuclear receptors (NRs) are a class of proteins that interact with steroid 
and  thyroid  hormones,  as  well  as  certain  other  proteins,  to  regulate 
transcription  in  response  to  ligands.  By  regulating  the  expression  of 
specific genes, NRs control diverse aspects of the organism such as 
embryonic  development  and  adult  homeostasis  (Mangelsdorf  et  al., 
1995; Robinson-Rechavi et al., 2003).  
NRs have the ability to bind to DNA and regulate the expression of 
adjacent genes when activated by ligands; hence, they are classified as 
members  of  the  transcription  factor  family  of  proteins  (Evans,  1988; 
Olefsky, 2001). NRs are divided into two broad classed according to 
their mechanism of action. Type I NRs are located in the cytosol in the 
absence of the ligand. Hormone binding facilitates the dissociation of  
 
   
10 
heat  shock  protein  (HSP)  from  NR,  allowing  NR  dimerization  and 
translocation  to  the  nucleus  to  bind  to  genomic  DNA.  The  NR/DNA 
complex recruits other proteins to regulate transcription and eventually 
the cell functions. Members of Type I NRs include androgen receptor 
(AR),  estrogen  receptor  (ER),  glucocorticoid  receptor  (GR), 
progesterone  receptor,  as  well  as  orphan  receptors  (Linja,  2004).  In 
contrast to Type I, Type II NRs are located in the nucleus regardless of 
the presence of ligands. Without ligands, Type II NRs bind to the co-
repressor proteins; however, ligand binding leads to dissociation of co-
repressor and recruitment of the co-activator proteins to regulate gene 
expression.  Retinoic  acid  receptors  (RAR  α, β  and γ),  retinoid  X 
receptors  (RXR  α, β  and γ)  and  thyroid  hormone  receptor  (TR)  are 
members of the Type II NRs (Mangelsdorf et al., 1995; Klinge et al., 
1997; 1999). 
 
1.2.2 Chicken ovalbumin upstream promoter transcription factors 
(COUP-TFs) 
Chicken  ovalbumin  upstream  promoter  transcription  factors  (COUP-
TFs) were originally identified to bind to the upstream promoter region 
of  the  ovalbumin  gene  to  activate  its  transcription  (Pastorcic  et  al., 
1986; Sagami et al., 1986; Wang et al., 1987; Pereira et al., 1995).  
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They  are  members  of  the  Type  I  NR  superfamily  and  classified  as 
orphan  receptors  as  no  ligand  has  been  identified  for  COUP-TFs  to 
date (Pereira et al., 1995; Kruse et al., 2008).  
COUP-TFs  are  generally  considered  as  transcription  repressors  with 
different  mechanisms  of  action.  For  example,  COUP-TF  has  been 
shown to bind promiscuously to a variety of different repeats including 
the AGGTCA motif and hormone response elements of VDR, TR and 
RAR, leading to silencing of basal transcription activity (Tsai, 1997). It’s 
also well known that COUP-TF forms heterodimers with RXRs, which is 
a  universal  partner  for  other  nuclear  receptors  such  as  VDR,  RAR, 
PPAR and other orphan receptors (Tsai, 1997). This mechanism may 
involve  the  recruitment  of  nuclear  receptor  repressor  (NCoR)  and 
silencing mediator for retinoid and thyroid hormone receptor (SMRT), 
which bind to RAR and TR in the absence of ligands (Tsai, 1997). Other 
possible  mechanisms  involve  active  repression  and  transrepression 
(Tsai, 1997).  
 
1.2.3 COUP-TF interacting proteins 
COUP-TF  interacting  proteins  (CTIPs)  were  observed  to  interact 
directly  with  COUP-TF  family  members  (COUP-TFI/NR2F1,  COUP-
TFII/ARP1/NR2F2 and COUP-TFIII/EAR2/NR2F6) in yeast and in vitro  
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(Avram et al., 2000). CTIP1 (BCL11A, EVI9) and CTIP2 (BCL11B, RIT-
1b) are highly related members of the CTIP family, which share high 
sequence  identity  over  the  entire  protein,  and  contain  several 
conserved  C2H2  zinc  finger  motifs  (Avram  et  al.,  2000)  (Figure  1.2). 
They have been shown to repress the transcription of genes harbouring 
COUP-TF regions by binding to the canonical GC box (Avram et al., 
2002). As mediators of transcriptional repression, their activity has been 
found to be insensitive to reversal by trichostatin A (TSA), an inhibitor of 
histone deacetylases (HDACs) ( Avram et al., 2000; Topark-Ngarm et 
al., 2006). 
 
1.2.4 COUP-TF interacting protein 1 (Ctip1) 
Developmental  studies  in  mice  have  shown  that  expression  of  Ctip1 
starts  as  early  10.5  days  post-coitum  embryos  (P10.5)  in  a  diffused 
pattern in forelimb bud, branchial arches and CNS (Avram et al., 2000; 
Leid et al., 2004). Its expression became more restricted at later stages 
at  E12.5  and  E14.5  with  the  highest  expression  in  the  developing 
forebrain (Leid et al., 2004). CNS expression of Ctip1 remains strong 
with  low  diffuse  expression  throughout  the  E18.5  fetus  (Leid  et  al., 
2004).  
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In humans and mice, CTIP1 is also expressed in several hematopoietic 
tissues such as bone marrow, splenic B and T cells, monocytes and 
germinal  B  cells  (Liu  et  al.,  2003).  Several  reports  indicated  the 
important role of CTIP1 as a myeloid or B cell proto-oncogene in mice 
and humans as it is a common site of retroviral integration in myeloid 
leukemia (Nakamura et al., 2000; Satterwhite, 2001; Uda et al., 2008). 
CTIP1  is  also  required  for  normal  lymphoid  development  as  well  as 
human fatal hemoglobin expression (Liu et al., 2003; Sankaran et al., 
2008). 
 
1.2.5 COUP-TF interacting protein 2 (Ctip2) 
Both mouse Ctip2 and human CTIP2 gene contains 4 exons with the 
majority of its open reading frame (ORF) encoded by exon 4 (Figure 
1.2).  The  expression  of  Ctip2  during  mouse  development  shares  a 
similar  pattern  with  Ctip1.  It  is  expressed  diffusely  at  E10.5  and 
becomes more restricted at E12.5 in the same region as Ctip1, except 
in the cerebellar domain as well as mandibular and nasal mesenchyme 
(Leid  et  al.,  2004).  A  relatively  high  expression  level  of  Ctip2  was 
observed to be expressed in thymus at E14.5 when most of the thymic 
cells  are  CD4
-CD8
-.  The  thymus  becomes  the  most  dominant  organ 
that expresses Ctip2 at E18.5. Ctip2 expression has been detected in  
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the developing mice skin and in adult mice and human skin (Golonzhka 
et al., 2007; Ganguli-Indra et al., 2009a) Ctip2 expression was found to 
be upregulated in the skin of human AD patients and allergic contact 
dermatitis (ACD) patients (Ganguli-Indra et al., 2009a)    
Ctip2 has been reported to interact with nucleosome remodelling and 
deacetylation  (NuRD)  complex  with  histone  deacetylase  activity  and 
repress  the  transcription  of  target  genes  such  as  p57KIP2  (Topark-
Ngarm et al., 2006).  However, new evidence suggested the role of 
Ctip2  as  a  transcriptional  activator.  One-third  of  all  Ctip2-regulated 
genes  in  thymocytes  are  activated  by  Ctip2  (Kastner  et  al.,  2010). 
Ablation of Ctip2 in mouse embryonic skin leads to downregulation of 
several  genes  involved  in  skin  lipid  homeostasis  (Wang  et  al,  2012, 
submitted). Hence, Ctip2 could also activate transcription under certain 
biological conditions. 
As Ctip2 null mice die perinatally, several studies have investigated the 
possible  causes  of  the  lethality.  Ctip2  null  mice  show  defects  in 
thymocyte  development  and  rearranged  T  cell  receptors  (TCR) 
signalling, suggesting Ctip2 is required in differentiation and survival of 
T lymphocytes (Wakabayashi et al., 2003). Ctip2 also plays a critical 
role in the development of corticospinal motor neuron (CSMN) axonal 
projections to the spinal cord in vivo (Arlotta et al., 2005). Thymocytes  
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isolated from Ctip2 null newborn mice exhibit increased vulnerability to 
DNA replication stress and damage, which leads to increased apoptosis 
(Kamimura  et  al.,  2007;  Karanam  et  al.,  2010).    Recent  reports 
suggested  crucial  roles  of  Ctip2  in  tooth  and  skin  development 
(Golonzhka et al., 2007, 2008, 2009). 
 
1.3 The role of Ctip2 in skin development and homeostasis  
 
1.3.1 Ctip2 expression in mouse developing skin 
Ctip2 expression is detected in the ectoderm as early as E10.5 in the 
outermost layer of skin. Some of the positive cells also express keratin 
14  (K14),  which  is  the  marker  of  the  basal  layer  (Golonzhka  et  al., 
2007). Embryonic basal layer is formed at E12.5, in which every cell is 
found to express Ctip2 (Golonzhka et al., 2007). Strong expression of 
Ctip2 is observed at E14.5, mainly in the basal layer and suprabasal 
layer of the epidermis. Further investigation of Ctip2 expression was 
performed on E16.5 and E18.5 mouse skin. Ctip2 expression remains 
high in the basal layer at both stages with small groups of positive cells 
in  the  suprabasal  layer.  Also,  Ctip2  expression  was  found  in  hair 
follicles and hair bulbs at later developmental stages with a few positive  
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cells  in  the  dermis  (Golonzhka  et  al.,  2007).    Ctip2  expression  is 
overlapping  with  cell  proliferation  marker  Ki67  positive  signals  in  the 
epidermis  and  hair  follicles  at  majority  of  developmental  stages, 
indicating  that  Ctip2  positive  cells  are  highly  proliferative  during  skin 
development (Golonzhka et al., 2007) (Figure 1.3). 
 
1.3.2 Ctip2 expression in adult mouse skin 
Similar  to  embryonic  skin,  in  8-10  week-old  mouse  skin,  Ctip2  is 
expressed in most of the cells in the basal layer, and some cells in the 
suprabasal  layer  and  hair  follicles.    However,  Ctip2  can  be  barely 
detected in the dermal compartment. Compared with E18.5 embryos, 
the expression level is much lower in the adult skin (Golonzhka et al., 
2007). Ctip2 is also expressed in the bulge region of adult mouse hair 
follicles, which harbour stem cells and contribute to the generation of 
hair follicle and inter-follicular epidermis (Golonzhka et al., 2007). 
 
1.3.3 Ctip2 in epidermal barrier formation 
As  Ctip2  null  mice  die  after  birth,  it’s  likely  that  these  mice  have 
epidermal defects, together with other developmental abnormality. An 
X-gal diffusion assay was performed to determine the barrier function at  
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E17.5 and E18.5. Ctip2 null mice, but not wildtype, show strong X-gal 
staining at E17.5, especially on the ventral surface and head, indicating 
a  delayed  dorsal  to  ventral  barrier  establishment  in  the  null  mice 
(Golonzhka et al., 2008) (Figure 1.4.A). Similar assays performed at 
E18.5 didn’t reveal any significant difference between wildtype and null 
mice  (Figure  1.4.A).  Trans-epidermal  water  loss  (TEWL)  studies 
indicate  that  Ctip2  null  embryos  have  significant  higher  water  loss 
compared with wildtype at E17.5 and E18.5 (Figure 1.4.B). Ctip2 null 
mice also exhibited reduced epidermal thickness at E17.5 with defects 
in  proliferation  and  differentiation  (Golonzhka  et  al.,  2008)  (Figure 
1.4.D-E). Real-time quantitive PCR (RT-qPCR) studies performed on 
wildtype and Ctip2 null mice revealed downregulation of genes involved 
in  epidermal  terminal  differentiation  and  barrier  formation  in  the  null 
mice,  such  as  transglutaminase-1  (Tgase1),  Gata3,  and  caspase-14 
(Golonzhka  et  al.,  2008).  Hence,  Ctip2  regulates  epidermal  barrier 
formation during embryonic development by modulating the expression 
of  genes  involved  in  barrier  formation  and  terminal  differentiation 
(Golonzhka et al., 2008). 
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1.3.4 Ctip2 in epidermal surface lipid distribution 
By Nile Red staining, dense and evenly distributed neutral lipids were 
stained in the wildtype fetus along the cornified layer, while uneven and 
thinner neutral lipid layer was observed in the Ctip2 null mice at E17.5 
(Golonzhka  et  al.,  2008)  (Figure  1.4.C).  The  ultrastructure  of  the 
epidermis also revealed defects in lipid disc formation, loosely packed 
corneocytes,  as  well  as  disorganized  intercellular  lamellar  body 
membranes  in  the  cornified  layer  of  Ctip2  null  mice  compared  with 
wildtype (Golonzhka et al., 2008). These results indicated impaired lipid 
distribution following ablation of Ctip2 during development (Golonzhka 
et al., 2008). 
The  defects  in  neutral  lipid  distribution  and  irregular  lamellar  body 
formation in the mutant mice could be due to changed gene expression 
profile. Several genes involved in lipid homeostasis were studied with 
RT-qPCR. Dgat2, Elovl4, eLox3 and Alox12b were downregulated in 
the  null  embryos  at  E17.5,  suggesting  that  Ctip2  could  regulate  the 
expression of lipid homeostasis genes, thus contributing to lipid barrier 
formation during development (Golonzhka et al., 2008). 
1.3.5 Ctip2 and cornified envelop (CE) formation 
Ctip2  also  has  an  important  role  in  epidermal  barrier  formation  by 
regulating the formation and integrity of CEs (Figure 1.5, unpublished  
 
   
19 
data). CE suspension was sonicated for different lengths of time and 
the  morphology  of  the  CEs  were  monitored  using  a  phase  contrast 
microscope.  The  mutant  CEs  were  less  in  number,  morphologically 
abnormal and irregular in shape compared to the wildtypes. Also, the 
mutant CEs were more fragile during sonication, and were completely 
destroyed after 2 minutes of sonication. Thus, Ctip2 may regulate the 
epidermal barrier by involving in the formation of functional and integral 
CEs. 
  
1.4 CTIP2 and skin diseases 
 
1.4.1 Expression of CTIP2 in human head and neck squamous cell 
carcinoma (HNSCC) 
Head and neck cancer is the 6
th most common cancer in the world. In 
United States, head and neck cancer accounts for less than 5% of all 
cancers and less than 3% of all cancer deaths. The most common type 
of head and neck cancer is head and neck squamous cell carcinoma 
(HNSCC) (Hunter et al., 2005). Disappointingly, the survival rate of this 
disease cannot be improved even with aggressive and multidisciplinary 
treatment and medicine currently available. The localization of CTIP2 in  
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human HNSCC was studied by immunohistochemical staining (Ganguli-
Indra et al., 2009b). In tumor adjacent normal epithelium tissue, CTIP2 
is exclusively observed in the nucleus of basal layer keratinocytes. In 
dysplasia  samples,  the  expression  of  CTIP2  is  much  stronger  than 
normal tissue, with extended expression in the spinous layer. In well-
differentiated tumors, CTIP2 expresses in basal layer of the keratinized 
horn  pearl.  Moderately  and  poorly  differentiated  tumors  showed 
homologous and strong CTIP2 staining (Ganguli-Indra et al., 2009b). 
Overall,  increased  expression  of  CTIP2  correlated  well  with  the 
progression  of  carcinoma  (Ganguli-Indra  et  al.,  2009b).  CTIP2 
expression has been reported to be linked to poor differentiation status 
of the tumor (Ganguli-Indra et al., 2009b). 
The  expression  level  of  CTIP2  in  human  cell  lines  confirmed  above 
results.  Low  level  of  CTIP2  is  found  in  primary  human  epidermal 
keratinocytes  (Hek-a)  and  in  spontaneously  immortalized  non-
tumorigenic human skin keratinocytes (Hacat), while high expression of 
CTIP2 has been detected in head and neck carcinoma cell lines (SCC4, 
SCC25,  etc)  and  other  carcinomas  (Ganguli-Indra  et  al.,  2009b). 
Altogether, results indicate that CTIP2 expression is linked to HNSCC 
progression. 
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1.4.2 Role of Ctip2 in cutaneous wound healing 
Cutaneous  wound  healing  is  a  highly  organized  process  involving 
crosstalk  between  different  cell  types,  epidermal  barrier  homeostasis 
recovery, as well as re-epithelialization carried out by cell migration and 
proliferation  (Gurtner  et  al.,  2008).  Various  pathways  regulate  this 
process with key factors such as integrins, stem cell markers, growth 
factors, cytokines as well as other regulatory proteins (Werner et al., 
2007; Barrientos et al., 2008; Liang et al., 2012). 
Tape  stripping  creates  a  model  for  mechanical  skin  injury  in  mouse 
skin. It induces transient epidermal hyperplasia with altered epidermal 
proliferation and differentiation (Oyoshi et al., 2010). Another model to 
study more several mechanical injuries is to create an excisional wound 
in mouse skin and monitor the healing process by measurement of the 
gap between the migratory tongues from the wound site (Wong et al., 
2011). In wildtype mice, the expression level of Ctip2 increases after 
24-48 hours post tape stripping, and 7-11 days post wounding, mainly 
expressed in epidermal basal layer as well as post-mitotic suprabasal 
layers during later phases of wound healing (Liang et al., 2012). 
Since Ctip2 null mice die after birth, a new mouse line was generated in 
which  Ctip2  is  selectively  deleted  in  mouse  epidermal  keratinocytes 
(Ctip2
ep-/-) using Cre-LoxP strategies and K14/Cre deletor mice (Indra et  
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al.,  1999;  Golonzhka  et  al.,  2008).  Ctip2
ep-/-  mice  exhibit  increased 
epidermal proliferation and terminal differentiation in unwounded skin. 
After wounds were created, the mutant mice show significantly delayed 
wound healing with lower re-epithelialization efficiency compared with 
wildtype. Also, Ctip2
ep-/- mice have thick and blunted migratory tongues 
in the wound margin while the wildtypes have thinner ones. The mutant 
mice  also  have  impaired  keratinocyte  activation  and  altered  cell 
proliferation and differentiation, which could contribute to the delayed 
cutaneous wound healing (Liang et al., 2012). Altogether, Ctip2 plays a 
critical  role  in  mouse  skin  wound  healing  and  re-epithelialization  by 
regulating keratinocyte activation, proliferation and differentiation in a 
cell-autonomous manner(Liang et al., 2012). 
During mice skin wound healing, the expression of alpha SMA which is 
responsible for development of extracellular matrix (ECM) was reduced 
in the mutant on day 5 after wounding. Several stem cell markers, such 
as K15, CD133 as well as CD34 were significantly downregulated in the 
Ctip2
ep-/- mice 5 days post wounding. These results indicate aberrant 
expression levels of regulatory proteins in the mouse cutaneous wound 
healing process in the absence of Ctip2 (Liang et al., 2012). 
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1.5 Research objectives 
 
In the study described under Chapter 2, we have evaluated how Ctip2 
regulates lipid composition in mouse epidermis in connection to the role 
of  Ctip2  in  epidermal  permeability  barrier  formation.  The  molecular 
mechanisms of Ctip2 mediated regulation of sphingolipids biosynthesis 
were also addressed. 
 
In Chapter 3, our study focused on the regulation of adult skin barrier 
maintenance  and  homeostasis  by  Ctip2.  The  role  of  Ctip2  in  atopic 
dermatitis-like  mouse  skin  inflammatory  disease  was  studied.  Key 
factors involved in this disease progression were identified.  
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Figure  1.1  Schematic  representation  of  epidermal  permeability 
barrier. (Adapted from Segre et al., 2006). 
Epidermal  keratinocytes  undergo  a  series  of  proliferation  and 
differentiation from basal cells to spinous cells to enucleated granular 
cells, resulting finally in differentiated squames in the stratum corneum, 
which  is  composed  of  keratin  macrofibrils  and  cross-linked  cornified 
envelopes  (CEs).  Tight  junction  also  plays  an  important  role  in 
epidermal permeability barrier. 
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Figure 1.2 Amino acid sequence, diagram of amino acid sequence 
alignment of CTIP1 and CTIP2. (Taken from Avram et al., 2000) 
(A)  and  (B) Amino acid sequence of CTIP1 and CTIP2, respectively. 
The  conserved  cysteine  and  histidine  in  zinc  finger  motifs  for  both 
proteins are underlined.  
(C)  Schematic  diagram  of  CTIP1  and  CTIP2  amino  acid  alignment. 
Black boxes indicate homologous regions between CTIP1 and CTIP2, 
and percentage of identity is listed.  
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Figure 1.3 Expression of Ctip2 in the mouse fetal skin. (Adapted 
from Golonzhka et al., 2007) 
(A)  Highly expressed Ctip2 (green) was observed in the ectoderm at 
E10.5 (upper panel) and E12.5 (lower panel) and is co-localized with 
the expression of K14 (red). 
(B) Ctip2 expression was mainly in the basal cells and upper layers of 
the epidermis of E14.5 (upper panel), E16.5 (middle panel) and E18.5 
embryos  (lower  panel).  Ctip2  (red)  was  co-stained  with  K14  (basal 
layer) and K10 (suprabasal layer) (in red). At E16.5 and E18.5 stages of 
development CTIP2 is highly expressed in the basal layer of epidermis 
as  well  as  in  the  dermis  and  hair  follicles.  All  sections  were 
counterstained  with  DAPI  (in  blue).  Images  were  taken  at  40X 
magnification. EC: ectoderm, M: mesoderm, E: epidermis, D: dermis, B: 
basal  cell  layer,  SB:  suprabasal  cell  layers,  HB:  hair  bulb,  HF:  hair 
follicle.  
 
   
28 
 
!"
#"
$"
%"
"
"
"
"
"
&" 
 
   
29 
Figure 1.4 Ctip2 mutant mice exhibit permeability barrier defects 
and epidermal hypoplasia. (Adapted from Golonzhka et al., 2007) 
(A) X-gal diffusion assay performed on wildtype and Ctip2 null mice at 
E17.5 and E18.5. 
(B)  Transepidermal  water  loss  (TEWL)  measurement  of  E17.5  and 
E18.5  embryonic  dorsal  and  ventral  skin.  *P<0.05,  #  not  statistically 
significant. 
(C) Nile red staining of wildtype and Ctip2 null mice at E18.5. Yellow 
ribbon  indicates  neutral  lipid  layer.  Yellow  arrows  indicate  loss  of 
neutral lipid in the Ctip2 null epidermis. Scale bar: 50 µm. E, epidermis; 
D, dermis. 
(D) Immunohistochemical staining of wildtype and null mice dorsal skin 
at  E18.5  with  proliferation  markers  Ki67  (red),  K14  (red)  and  early 
differentiation marker K10 (red). 
(E) Immunohistochemical staining of wildtype and null mice dorsal skin 
at E18.5 with terminal differntiation markers Filaggrin (red), Involucrin 
(red)  and  Loricrin  (red).  All  sections  were  counterstained  with  DAPI 
(blue). Scale bar: 100 µm.  
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Figure 1.5 Ctip2 is required for the formation and integrity of cornified 
envelope in mouse epidermis. 
Pictures  represent  the  morphology  of  cornified  envelope  extracted  from 
wildtype and Ctip2
ep-/- after different time of sonication.  
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2.1 Abstract 
 
The stratum corneum is composed of a continuous sheath of protein-
enriched corneocytes embedded in an intercellular matrix enriched in 
nonpolar  lipids  organized  as  lamellar  layers  and  give  rise  to  the 
epidermal  permeability  barrier  (EPB).  EPB  defects  play  an  important 
role  in  the  pathophysiology  of  skin  diseases  such  as  eczema.  The 
transcriptional control of skin lipid metabolism is poorly understood. We 
have  discovered  that  mouse  lacking  a  transcription  factor  COUP-TF 
interacting  protein  2  (Ctip2)  exhibit  EPB  defects  including  altered 
keratinocyte terminal differentiation, delayed skin barrier development 
and interrupted neutral lipid distribution in the epidermis. We adapted 
herein a targeted lipidomics approach using mass spectrometry, and 
have  determined  that  Ctip2
-/- mice  (germline  deletion  of  Ctip2  gene) 
display altered composition of major epidermal lipids such as ceramides 
and sphingomyelins compared to the wildtype at different stages of skin 
development.  Interestingly,  expressions  of  several  genes  involved  in 
skin sphingolipid biosynthesis and metabolism were altered in mutant 
skin. Ctip2 was found to be recruited to the promoter region of a subset 
of those genes, suggesting their possible direct regulation by Ctip2. Our 
Ctip2 mouse model exhibiting EPB defects can be utilized to screen for 
new drugs for treatment and recovery of barrier dysfunctions.  
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2.2 Introduction 
The exterior layer of skin, stratum corneum (SC), plays a critical role in 
skin  permeability  barrier  formation  and  maintenance  (Fuchs  and 
Raghavan,  2002;  Elias,  2004).  It  forms  a  protective  barrier  against 
external  stress  and  environmental  insults.  Skin  barrier  defects  are 
caused not only by altered levels of protein(s) involved in keratinocytes 
terminal  differentiation,  cross-linking  of  cornified  envelops  (CEs),  but 
also by impaired formation and maintenance of skin lipid barrier (Elias 
and  Menon,  1991;  Nemes  and  Steinert,  1999;  Feingold,  2007). 
Mammalian SC contains a large number of lipids, such as ceramides, 
sphingomyelins, cholesterols and fatty acids (Elias and Menon, 1991; 
Ishikawa et al., 2010). Ceramides (CERs) are the most abundant lipid 
types in SC (50% by weight) and can be divided into at least 11 species 
(Oda  et  al.,  2008;  Ishikawa  et  al.,  2010).  It  has  been  shown  that 
reduced content of CERs leads to epidermal water loss as well as skin 
epidermal dysfunctions, and causes diseases such as atopic dermatitis 
(AD) or eczema (Imokawa, 2009; Ishikawa et al., 2010). Spingomyelins 
are another large group of epidermal sphingolipids, which have been 
reported as precursors of ceramides (Schmuth et al., 2000; Uchida et 
al., 2000; Holleran et al., 2006). Cholesterols and fatty acids are also 
major  skin  lipids,  and  cholesterol  3-sulfate  (CSO4)  is  a  ubiquitous  
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metabolite  of  cholesterol,  which  is  involved  in  cornified  envelope 
formation by interacting with transglutaminase1 (Nemes et al., 2000). 
Ceramide biosynthesis is regulated at multiple levels. Four pathways 
have  been  reported  so  far,  de  novo  pathway,  sphingomyelinase 
pathway, salvage pathway and exogenous ceramide recycling pathway 
(Kitatani et al., 2008). In de novo pathway, serine and fatty acyl-CoA 
are  the  initiators  of  a  series  of  reactions.    Ceramide  synthases  1-6 
(Lass1-Lass6)  play  an  important  role  since  each  of  them  has 
specificities on synthesizing certain ceramides (Mizutani et al., 2009). 
Other  enzymes  such  as  palmitoyltransferases  (Sptlc1-3), 
dihydroceramide  desaturase  (Degs1)  and  ketodihydro-sph  reductase 
(Kdsr)  are  also  key  enzymes  in  de  novo  pathway.    The  salvage 
pathway  has  been  reported  recently  as  a  complex  mechanism, 
commencing  as  the  catabolism  of  complex  sphingolipids  into 
glucosylceramid by glucosylceramide synthase (Ugcg), and followed by 
the formation of ceramide by acid beta-glucosidase (Gba2) (Ogretmen, 
2002;  Becker,  2004).  These  ceramides  can  be  broken  down  into 
sphingosines by acid ceramidase (Asah1 and Asah2), which are reused 
to  produce  ceramides.    In  sphingomyelinase  pathway,  ceramide  is 
formed  by  hydrolysis  of  sphingomyelins,  and  the  reverse  reaction  is 
controlled by sphingomyelin synthase (Marchesini and Hannun, 2004).  
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Exogenous  short  chain  ceramide  can  also  be  utilized  to  generate 
sphingosine,  thus  leads  to  the  synthesis  of  endogenous  long  chain 
ceramides (Ogretmen, 2002; Sultan et al., 2006). 
COUP-TF-interacting protein 2 (Ctip2), also known as Bcl11b, is a C2H2 
zinc  finger  protein  expressed  in  many  organs  and  tissues  including 
developing mouse epidermis (Avram et al., 2000, 2002; Golonzhka et 
al.,  2008).  It  has  been  reported  that  Ctip2  null  mice  exhibit  altered 
epidermal  proliferation  and  late  terminal  differentiation,  as  well  as 
barrier  defects  during  embryogenesis  (Golonzhka  et  al.,  2008).  The 
barrier defects were correlated with altered surface lipid distribution in 
the absence of Ctip2 (Golonzhka et al., 2008). 
Liquid  chromatography-tandem  mass  spectrometry  (LC/MS/MS)  has 
been  used  to  characterize  ceramide  species  in  mouse  and  human 
stratum corneum (Masukawa et al., 2008; Park et al., 2009; Ishikawa et 
al., 2010; Janssens et al., 2011; van Smeden et al., 2011). Here we 
adopted  the  LC/MS/MS  methodology  to  elucidate  the  CER  [NS], 
sphingmyelin and sphingosine profile in wildtype and Ctip2 null (Ctip2
-/-) 
embryonic  skin  epidermis.  The  expression  levels  of  genes  encoding 
various enzymes involved in sphingolipid metabolism were analyzed by 
RT-qPCR  and  immuno-blotting  in  wildtype  and  Ctip1-null  skin. 
Furthermore,  Ctip2  recruitment  to  the  promoter  regions  of  several  
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genes  that  were  altered  in  Ctip2
-/- mice  was  evaluated  by  chromatin 
immunoprecipitation  (ChIP)  analyses.  Results  indicated  that  Ctip2 
control  sphingolipid  metabolism  in  the  developing  skin  by  directly  or 
indirectly  regulating  expression  of  a  subset  of  genes  involved  in  the 
sphingolipid  bio-synthesis  pathways.  
 
2.3 Materials and methods 
 
Mice 
Ctip2   null (Ctip2
-/-) mice were generated by floxing exon 4 of Ctip2 
locus,  which  encodes  for  three-fourth  of  open  reading  frame  (ORF) 
(Golonzhka et al., 2008). OSU IACUC approval was obtained for animal 
experiments. 
 
Lipid extraction 
Fetus  from  E16.5  to  E18.5  and  neonatal  mice  were  collected  and 
genotyped (Golonzhka et al., 2008). A minimum of three wildtype and 
Ctip2
-/- fetuses were taken from the same litter and compared between 
littermates.  A  minimum  of  three  litters  were  analyzed  from  each 
developmental  stages.  Skin  was  isolated,  weighed  and  incubated 
overnight  in  CnT-07  medium  (CELLnTEC,  Bern,  Switzerland)  
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containing  1 mg ml
−1  dispase  (Gibco,  Grand  Island,  NY)  at  4 °C  to 
dissociate epidermis.  
Raw skin lipid was extracted using Bligh and Dyer method (Folch et al., 
1957; Bligh and Dyer, 1959). Briefly, skin epidermis was incubated in 
extraction  buffer  (chloroform:  methanol:  water  (1:2:0.8),  10-15mg 
tissue/1ml  extraction  buffer)  overnight  at  room  temperature.  Fresh 
extraction buffer was added to epidermis samples the second day and 
old extraction buffer was saved. Samples were sonicated for 5 cycles, 
30 seconds each, and the suspension was shaked for 30min in room 
temperature. After centrifuged at 2000rpm for 10min, the pellets were 
discarded  and  the  extraction  buffer  was  combined.  Chloroform  and 
water  were  added  to  extraction  buffer  in  a  ratio  of  extraction  buffer: 
chloroform: water (7.6: 2: 2). After mixing and centrifuging, upper phase 
was discarded and the lower phase (chloroform) was washed twice with 
chloroform:  methanol:  water  (1:  1:  0.9).  Lower  phase  was  dried  in 
nitrogen, weighed and saved in -20°C.  
 
LC-MS/MS 
Raw skin lipid was further purified as in previous reports (Merrilljr et al., 
2005; Monette et al., 2011). 10µl sphingolipid internal standard mixture 
(Avanti, Alabaster, Alabama) and 1mg raw lipid were added to 1.5ml of  
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chloroform: methanol (1:2) and sonicated in the bath sonicator for 30 
seconds. After 2 hours of incubation at 48 °C, the samples were cooled 
on ice. Samples were then incubated for 1 hour at 37°C with 75μl 1M 
KOH in methanol to remove the free fatty acids and triacylglycerol, and 
cooled on ice. 12μl of glacial acetic acid was added to neutralize the 
pH. Phase separation was achieved by adding 2ml chloroform and 4ml 
water and samples were gently vortexed. After centrifuge for 15 min at 
2000rcf, the chloroform layer was aspirated and dried under nitrogen. 
The  samples  were  reconstituted  in  200μl  chloroform:  methanol  (3:1) 
and  diluted  1:4  with  acetonitrile:  methanol:  acetic  acid  (97:2:1)  with 
5mM ammonium acetate. 
LC-tandem  mass  spectrometry  was  performed  and  relative 
quantification  was  based  on  skin  weight  and  sphingolipid  standards 
(Monette et al., 2011). In brief, lipids were separated by HPLC using a 
Supelco  Discovery  column  (2mm  x  50mm;  Sigma-Aldrich)  with 
300μl/min  flow  rate.  Mobile  phase  A:  methanol:  water  (60:40)  and 
mobile  phase  B:  methanol:  chloroform  (60:40)  both  contained  0.2% 
(v/v) formic acid and 10 mM ammonium acetate. The column was pre-
equilibrated  at  100%  phase  A  and  5μl  sample  was  injected;  100% 
mobile phase A was maintained for 1min, followed by a linear increase 
to 40% mobile phase B in a 7 min period; followed by a linear increase  
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to 70% mobile phase B in next 6 min, which was maintained for the 
remainder (6min) of the 20 min run. 
 Sample  detection  was  performed  using  a  triple-quadrupole  mass 
spectrometer  operated  in  positive  mode  (Applied  Biosystems/  MDS 
Sciex,  API300)  with  multiple  reaction  monitoring.  Quantitation  was 
based  on  comparison  to  a  synthetic  sphingolipid  standard  mixture 
(Monette et al., 2010). 
 
UPLC-MS/MS 
Ultra  high  pressure  liquid  chromatography  was  performed  on  a 
Shimadzu  Nexera  system  (Shimadzu,  Columbia,  MD)  coupled  to  a 
hybrid quadrupole-time of flight mass spectrometer (TripleTOF
TM 5600, 
AB  SCIEX)  with  raw  skin  lipids.  Chromatographic  separations  were 
carried out on a Brownlee Analytical C18 column (50 × 2.1 mm, 1.9 
mm; PerkinElmer, Boston, MA). The flow rate was 0.35 mL/min and 
mobile  phases  consisted  of  water  (A)  and  acetonitrile  (B),  both  with 
0.1% formic acid. Elution gradient was as follows: 0 min, 25% B; 2 min, 
55% B; 7 min, 100 % B; 9 min, 100% B. The column was equilibrated 3 
minutes prior to each injection. Column temperature was held at 40 °C 
and the injection volume was 3 µL.   
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Mass spectrometry was performed on an AB SCIEX TripleTOF
TM 5600 
equipped with an electrospray ionization source. The instrument was 
operated in information dependent MS/MS acquisition mode with the 
collision energy set at 30 V and a collision energy spread of 10 V. TOF 
MS acquisition time was 0.15 seconds and MS/MS acquisition time was 
0.10 seconds. Scan range was 70-1000 m/z for TOF MS and 40-1000 
m/z for MS/MS. Ion source gas 1 and 2 and curtain gas (all nitrogen) 
were set at 50 and 40 and 25, respectively. Source temperature was 
set at 500 °C and IonSpray voltage at 5.5/-5.5 kV. A set of standards 
was run periodically throughout the batch to assess system variance 
and  stability.  The  instrument  was  automatically  calibrated  every  five 
runs. 
Stearic acid, palmitic acid, cholesterol, and cholesterol-3-sulfate were 
identified using authentic standards with accurate mass measurements, 
isotope distribution, MS/MS fragmentation, and retention time. 
 
RT-qPCR 
RNA was extracted and cDNA was synthesized from fetus and neonatal 
skin  (Indra  et  al.,  2005b;  Wang  et  al.,  2011).  Real-time  PCR  was 
performed on an ABI 7500 Real-Time PCR system using SYBR green 
methodology  (Indra  et  al.,  2005a,  2005b).  Relative  gene  expression  
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analysis  of  the  RT-qPCR  data  was  performed  using  Gapdh  as  an 
internal control, and the specific primers were indicated in Table 2.1 
(Wang et al., 2011). All assays were performed in triplicates. 
 
Western blotting  
Protein was extracted from mouse skin biopsies and western blotting 
was performed due to previous reports using specific antibodies against 
Lass2, Gba2 and eLox3. (Wang et al., 2011; Santa Cruz Biotechnology, 
Santa Cruz, CA). Briefly, skin samples were homogenized, and proteins 
were  extracted
 with  a  lysis  buffer  (150mM  NaCl,  50mM  Tris  pH  7.5, 
5mM  EDTA,  and
  1%  Nonidet  P-40,  0.1%  SDS,  0.5%  sodium 
deoxycholate) containing protease inhibitors (2µg/ml Aprotinin, 2µg/ml 
Leupeptin, 100µg/ml Pefabloc and 1µg/ml Pepstatin).  Equal amounts
 
of protein extract (25 µg) from each lysate were resolved using SDS 
polyacrylamide-gel electrophoresis and transferred
 onto a nitrocellulose 
membrane. Blots were blocked overnight with 5% nonfat dry milk and 
incubated with specific antibodies. All western blot experiments were 
done in triplicates, using a minimum of three biological replicates from 
each group of mice. 
 
Chromatin immunoprecipitation (ChIP)  
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ChIP assay was performed according to Hyter et al., 2010 with minor 
modifications. Briefly, mouse keratinocytes were isolated from neonatal 
wildtype and Ctip2
-/- mice skin epidermis and fixed in 1% formaldehyde. 
Each  ChIP  started  with  3x10
6  cells,  which  are  sonicated  and 
immunoprecipitated with 2µg anti-Ctip2 antibody (Abcam, Cambridge, 
MA) overnight at 4°C. Rat IgG was used as control. 25ml protein G 
beads  (Invitrogen,  Carlsbad,  CA)  were  added  to  each  ChIP  and 
incubated  at  4°C  for  four  hours.  DNA  was  uncrosslinked  at  65°C 
overnight  and  purified  by  QIAquick  PCR  Purification  Kit  (Qiagen, 
Germantown, MD). DNA was amplified using ABI-7500 Real-time PCR 
machine with specific primers indicated in Supplementary table 2.  
 
Statistics 
Statistical  significance  of  differences  between  groups  was  analyzed 
using  GraphPad  Prism  software  using  student’s  unpaired  t-test.  All 
statistical analyses were performed in a double-blinded manner. 
 
2.4 Results  
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2.4.1 Altered profile of sphingolipids in the developing epidermis 
of Ctip2-null
 mice 
We  hypothesized  that  impaired  epidermal  permeability  barrier  in  the 
Ctip2-null (Ctip2
-/- )
 mice  could be  at least in part due to altered skin 
lipid    composition.  In  order  to  determine  the  lipid  composition  of 
embryonic  skin,  wildtype  and  Ctip2-null
  epidermis  were  isolated  at 
different developmental stages, E16.5, E17.5 E18.5 and neonatal (P0). 
Lipidomic studies were then performed using LC/MS/MS technique and 
absolute quantities of the different skin sphingolipids were analyzed (for 
details  see  materials  and  methods).  Both  ceramides  and 
sphingomyelins  were  abundant  during  mouse  skin  development, 
especially during the earlier stages of skin development (E16.5, E17.5) 
(Figure 2.1-2.4). 
Ceramide C14:0 level remained very low from E16.5-P0. Long chain 
ceramide C16:0 was the most abundant saturated ceramide at E16.5 
and was 2-fold higher in the mutant epidermis compared with wildtype 
(Figure 2.1 A). Significant induction of ceramide C18:0 was observed in 
the  E16.5  mutant  skin  (Figure  2.1  A).  The  amount  of  long  chain 
ceramides  (C16:0,  C18:0,  C20:0  and  C22:0)  was  in  a  very  low 
abundance  at  E17.5-E18.5,  with  no  discernable  difference  observed 
between wildtype and mutant skin; however, their quantities are larger 
at P0, each having a ~2-fold reduction in the Ctip2
-/- skin (Figure 2.1 B- 
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D). At E17.5 and E18.5, very long chain ceramide C26:0 became the 
dominant subtype in mouse skin, modestly reduced at E17.5 and 2-fold 
decreased at E18.5 in Ctip2
-/- skin (Figure 2.1 B-C). Modest decrease of 
ceramide C24:0 was also observed in Ctip2
-/- epidermis at P0 (Figure 
2.1  D).  Unsaturated  ceramides  were  less  abundant  compared  with 
saturated ceramides in the wild type epidermis. Long chain unsaturated 
ceramide  C16:1  was  significantly  reduced  at  E16.5  in  the  mutant 
epidermis, unaffected at E17.5 and E18.5, with a 2-fold decrease in P0 
mutant epidermis (Figure 2.2 A-D). 
Among  saturated  sphingomyelins,  long  chain  sphingomyelins  C16:0, 
C20:0  and  C22:0  were  the  most  abundant  subtypes  in  embryonic 
epidermis  at  most  of  the  stages,  which  were  highly  induced  in  the 
mutant skin, especially at E17.5 and E18.5 (Figure 2.3 B and C). Very 
long chain sphingomyelins (C24:1, C26:1, C28:1) were also increased 
in  the  mutant  skin  at  E16.5-E18.5  (Figure  2.3  A-C).    Interestingly, 
unsaturated  sphingomyelins  were  less  predominant  in  all 
developmental  stages;  however,  they  showed  the  similar  trend  as 
saturated ones, with higher amount in embryonic mutant epidermis. As 
early  as  E16.5,  long  chain  unsaturated  sphingomyelin  C24:1  was 
significantly elevated in Ctip2
-/- skin (Figure 2.4 A). Higher quantities of  
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long chain sphingomyelins C20:1, C22:1, and C24:1 were noted in the 
mutant epidermis at E17.5 and E18.5 (Figure 2.4 B-D). 
The profiles of sphingosine and sphinganine were also determined by 
LC/MS/MS.  Compared  with  ceramides  and  sphingomyelins,  the 
quantity of free sphingoid bases were smaller in embryonic skin, with no 
significant change observed between wildtype and mutant epidermis at 
all developmental stages (Figure 2.5 A-D). 
We  also  performed  UPLC/MS/MS  analyses  to  determine  the  relative 
amount  of  cholesterols  and  fatty  acids.  Levels  of  cholesterol  and 
cholesterol  3-sulfate  were  significantly  reduced  in  the  epidermis  of 
Ctip2
-/- mice at E16.5, but were unaltered at all later timepoints (Figure 
2.6 A-B). Although the amount of palmitic acid and stearic acid was 
similar  between  wildtype  and  null  skin  at  E16.5-E18.5,  their  levels 
doubled in the P0 Ctip2
-/- epidermis compared to the wildtype epidermis 
(Figure  2.6  C-D).  Altogether,  our  results  indicate  that  epidermal  lipid 
composition is altered in absence of transcriptional regulator Ctip2.   
2.4.2 Ctip2  directly  regulates  expression  of  a  subset  of  genes 
involved in lipid metabolism in the developing skin 
Previous  studies  have  identified  four  major  pathways  involved  in 
ceramide  synthesis:  de  novo  pathway,  salvage  pathway, 
sphingomyelinase pathway and exogenous ceramide-recycling pathway  
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(Kitatani  et  al.,  2008;  Mizutani  et  al.,  2009).  We  hypothesized  that 
altered  sphingolipid  profiles  in  mutant  mice  could  be  due  to  altered 
expression  of  genes  encoding  proteins  involved  in  the  sphingolipid 
metabolism.  To  test  that,  we  evaluated  the  expression  of  genes 
involved in the different ceramide biosynthesis pathways by RT-qPCR 
analyses  in  the  wild  type  control  and  mutant  skin  (for  details  see 
materials and methods). Expressions of ceramide synthase 3 (Lass3), 
palmitoyltransferases (Sptlc1 and Sptlc3) were downregulated at E16.5 
and  E17.5,  while  ceramide  synthases  Lass1  and  Lass2  were 
significantly reduced at E18.5 in Ctip2
-/- skin (Figure 2.7 A-C). Lass6 
was consistently downregulated from E16.5 to E18.5 in the mutant skin 
(Figure 2.7 A-C). Thus, genes encoding enzymes in de novo pathway 
were altered in ablation of Ctip2. Similarly, transcript levels of enzymes 
involved  in  sphingomyelinase  pathway  such  as  sphingomyelinases 
(Smpd1  and  Smpd2)  were  significantly  downregulated  at  E18.5, 
whereas  sphingomyelin  synthase  (Sgms2)  level  was  upregulated  at 
E16.5  in  null  embryos  compared  to  the  wildtypes  (Figure  2.7  D-F). 
Expression of glucosylceramide synthase (Ugcg), which turns complex 
sphingolipids into glucosylcerarimde, was also reduced at E18.5 while 
that  of  acid  beta-glucosidase  (Gba2),  which  is  involved  in  salvage 
pathway, was downregulated in skin of null mice from E16.5 to E18.5  
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(Figure 2.7 D-F). Ceramidases are involved in the breaking down of 
short-chain  ceramide,  facilitating  its  conversion  to  sphingosine.  In 
particular,  reduced  expression  of  acid  ceramidase  2  (Asah  2)  and 
alkaline  ceramidase  1  (Acer1)  was  observed  in  all  developmental 
stages  in  the  mutant  epidermis  (Figure  2.7  G-I).  Levels  of  all  other 
members  of  acid  ceramidases  (Asah  1  and  Asah  3)  and  alkaline 
ceramidases (Acer 2 and Acer 3) were unaltered in the mutants at all 
stages of development (Figure 2.7 G-I).  Similarly, sphingosine kinases 
(Sphk1,  Sphk2)  are  responsible  for  the  disposal  of  sphingosine  to 
sphingosine-1-phosphate,  whose  expression  level  was  reduced  at 
E16.5 in the mutant epidermis (Figure 2.7 G). No significant changes in 
the relative mRNA levels of several other enzymes involved in ceramide 
synthesis  pathways  was  observed  between  wildtype  and  Ctip2
-/- 
embryonic skin (Figure 2.7 G-I, 2.8 A-C). Furthermore, protein levels of 
Lass2, Gba2 and eLox3 were significantly reduced in the Ctip2 null skin 
compared with the wildtype skin at E18.5 (Figure 2.9 A-B) (Golonzhka 
et al., 2008). Taken together, our results indicate that expression of a 
subset  of  genes  encoding  enzymes  involved  in  the  sphingolipid 
biosynthesis  pathways  was  altered  during  skin  organogenesis  in 
absence of Ctip2. 
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To investigate whether some of the lipid-metabolizing genes, which are 
dysregulated  in  the  mutant  skin,  are  direct  targets  of  transcriptional 
regulator  Ctip2,  we  conducted  in  vivo  chromatin  immunoprecipitation 
(ChIP) assay on neonatal (P0) mouse epidermal keratinocyte extracts. 
The  promoter  regions  of  several  genes  encoding  lipid-metabolizing 
enzymes  such  as  Lass1-3,  6,  Sptlc1-3,  Smpd1-2,  Ugcg,  Gba2,  and 
eLox3 (Golonzhka et al., 2008), whose expressions were altered in the 
Ctip2
-/- skin,  were  selected  and  primers  were  designed  to  determine 
possible  Ctip2  binding  within  -6  kb  upstream  of  transcription  starting 
sites (TSS). Our results indicated that Ctip2 was recruited within -1 kb 
promoter region of Lass2, Gba2 and eLox3, as well as between 5-6 kb 
promoter region of eLox3 relative to TSS (Figure 2.10 A-C). However, 
we  did  not  observe  the  direct  recruitment  of  Ctip2  to  the  promoter 
regions of several other lipid-metabolizing genes (Figure 2.11 A-K). Our 
results indicate that Ctip2 is directly recruited to the promoter region of 
a  subset  of  lipid  metabolizing  genes  and  possibly  regulates  their 
expression  in  the  developing  epidermis.  Altogether,  results  suggest 
that Ctip2 directly or indirectly regulates expression of a  subset  of  lipid  
metabolizing  genes and  control epidermal  sphingolipid biosynthesis 
during skin organogenesis.  
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2.5 Discussion 
 
The establishment of an effective physical barrier protecting the living 
organism  from  its  surrounding  environment  is  the  key  function  of 
mammalian skin (Hoffjan and Stemmler, 2007). The transport of most 
substances across the stratum corneum (SC) takes place through the 
lipid  bilayer,  suggesting  its  essential  role  for  the  epidermal  barrier 
function  (Jungersted  et  al.,  2008).  The  major  SC  lipids,  ceramides, 
cholesterol  and  fatty  acids  have  distinct  roles  in  maintaining  normal 
barrier  functions  (Elias  and  Menon,  1991;  Ishikawa  et  al.,  2010). 
Ceramides as well as cholesterol were shown to have an influence on 
(and are influenced by) the integrity of the SC, while free fatty acids 
play  a  major  role  in  the  lipid  bilayer  formation  and  pH  maintenance 
(Baroni et al., 2012). We have identified Ctip2 as a key regulator of skin 
lipid  metabolism,  which  plays  an  important  role  in  establishment  of 
epidermal permeability barrier (EPB) during development. Ablation of 
Ctip2  leads  to  altered  lipid  composition  in  the  developing  mouse 
epidermis, such as reduced ceramide at E17.5-P0, as well as increased 
sphingomyelins  at  E16.5-E18.5.    Ctip2  regulate  sphingolipid 
homeostasis in mouse embryonic skin by modulating the expression of 
several  key  enzymes  involved  in  lipid  metabolism.  Here  we 
demonstrate that transcription factor Ctip2 is recruited to the promoter  
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regions of a subset of genes (elox3, Lass2 and Gba2) involved in the 
sphingolipid  biosynthesis  pathways  and  could  directly  regulate  their 
expression (Figure 2.12).  
Skin barrier defects are caused not only by altered levels of protein(s) 
involved  in  keratinocytes  terminal  differentiation,  cross-linking  of 
cornified envelops (CEs), formation of intercellular junctions, but also by 
impaired formation and maintenance of skin lipid barrier (Furuse et al., 
2002; Kirschner and Brandner, 2012). Our previous studies have shown 
that  Ctip2  regulate  keratinocyte  proliferation  and  late  terminal 
differentiation in a cell-autonomous manner; the ultrastructural analyses 
of the epidermis have revealed defects in lipid disc formation, loosely 
packed corneocytes, as well as disorganized intercellular lamellar body 
membranes in Ctip2 null mice (Golonzhka et al., 2008 and unpublished 
data). In this study, we have focused on the role of Ctip2 in controlling 
epidermal lipid barrier by modulating lipid metabolism. Herein, we have 
applied a mass spectrometry method to systemically detect and profile 
ceramides,  sphingomyelins,  sphingosines  and  sphinganines 
simultaneously in murine epidermis. As a crucial member of stratum 
corneum  lipids,  there  are  few  reports  on  profiling  of  skin 
sphingomyelins. Our present data confirm deregulated levels of both 
long chain and very long chain saturated and unsaturated ceramides in  
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the mutant epidermis at different stages of skin development. Along the 
same line, overall levels of long chain and very long chain saturated 
and  unsaturated  sphingomyelins  were  significantly  enhanced  in  the 
mutants  at  all  stages  analyzed.  In  the  present  study,  we  have 
specifically looked at ceramide [NS] but were unable to perform mass-
spectrometry study on other subclasses such as NP, NH, AS, AP, AH, 
EOS, EOP and EOH, due to the lack of available deuterated ceramide 
internal  standards  for  each  subclasses.  Additional  analyses  for  the 
different subclasses will be performed in future using specific internal 
standard for each subclass.  
Our results indicate that altered expression(s) of ceramide synthases 1-
6  (Lass  1-6),  sphingomyelinases  (Smpd1  and  Smpd2), 
glucosylceramide  synthase  (Ugcg)  and  that  of  acid  beta-glucosidase 
(Gba2) at different stages of skin development contribute to an overall 
decrease  in  the  epidermal  ceramide  levels  in  the  mutant  embryonic 
skin.  Lass  1-6  have  been  reported  to  be  involved  in  UVB-induced 
apoptosis and their expression was increased after UVB irradiation in 
normal human keratinocytes, but reduced in aged skin (Uchida et al., 
2003;  Jensen  et  al.,  2005).  A  recent  study  has  reported  that  Lass3 
mutant  mice  die  after  birth  due  to  increased  skin  barrier  defects, 
characterized by increased TEWL, loss of ultra-long chain ceramides as  
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well  as  non-functional  cornified  envelopes  (Jennemann  et  al.,  2011). 
Upregulation of sphingomyelin synthase (Sgms2) in Ctip2
-/- mice may 
partially account for increased amount of sphingomyelins observed at 
later  stages  in  the  mutant  skin  (Figure  2.3  B-C(Wang  et  al.,  2011)).  
Furthermore, loss of Gba2, whose expression is altered in the mutant 
epidermis, has been reported to lead to barrier defects in Gaucher’s 
disease patients (Holleran et al., 1994). Similarly, eLox3 as well as its 
substrate 12R-lipoxygenase (12R-LOX) are involved in the formation of 
oxidized ceramides in mouse epidermis; 12R-LOX deficient mice die 
shortly after birth due to severe barrier abnormalities with absence of 
protein-bound  EOS  ceramide  (Zheng  et  al.,  2011).  Interestingly,  we 
have  reported  earlier  that  eLox3  expression  is  downregulated  in  the 
Ctip2
-/-  embryonic  skin  (Golonzhka  et  al.,  2008).  Here  we  have 
furthered our studies and have shown that Ctip2 could directly regulate 
the expression of eLox3, Gba2 and Lass2 in mouse embryonic skin by 
recruitment  to  their  promoter  regions.  Altogether,  we  have  identified 
Ctip2 as a key regulator of several lipid metabolizing genes and hence 
epidermal sphingolipid biosynthesis during skin development. 
Sphingolipids are key components in skin barrier homeostasis, as well 
as in other cellular processes such as cell cycle arrest, apoptosis and 
stress  responses  (Hannun,  1996;  Ogretmen  and  Hannun,  2004).  
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Ceramide is a central metabolite, whose biosynthesis is regulated at 
multiple levels with spatial separation of enzymes involved in ceramide 
formation  (Futerman  and  Riezman,  2005;  Kitatani  et  al.,  2008).    It 
remains unclear that if alteration of the enzymes in one of the pathways 
could  have  an  effect  on  other  pathways,  and  finally  modulate  the 
biological functions. It would be interesting to systemically compare the 
lipid  composition  in  healthy  subjects  vs  patients  with  skin  disorders 
such as atopic dermatitis and psoriasis. It is likely possible that besides 
Ctip2,  other  regulatory  pathways  are  also  involved  in  controlling 
ceramide biosynthesis. B-cell lymphoma/leukemia 11A (Bcl11a/Ctip1) is 
a homolog of Ctip2, which was found to be upregulated in Ctip2 null 
mice at E18.5 (Golonzhka et al., 2008). The role of Ctip1 in epidermal 
barrier  development  and  maintenance  is  still  unclear.  Further 
investigation about the expression pattern and distribution of Ctip1, as 
well as its role in lipid barrier homeostasis in mouse epidermis will be 
performed utilizing Ctip1
-/- mice.  
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Figure  2.1  Liquid  chromatography  tandem  mass-spectrometry 
(LC/MS/MS)  analyses  of  mouse  epidermal  saturated  ceramides 
during skin development.  
Epidermal  sphingolipids  were  extracted  from  skin  of  (A)  E16.5;  (B) 
E17.5;  (C)  E18.5  embryos  and  (D)  P0  wildtype  and  Ctip2
-/-  mice. 
Amount of saturated ceramides was determined according to their N-
acyl chain length using LC/MS/MS analyses. Statistical analyses were 
performed by student’s unpaired t-test using Graphpad Prism software. 
*p<0.05. 
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Figure  2.2  Liquid  chromatography  tandem  mass-spectrometry 
(LC/MS/MS) analyses of mouse epidermal unsaturated ceramides 
during skin development. 
Epidermal  sphingolipids  were  extracted  from  skin  of  (A)  E16.5;  (B) 
E17.5;  (C)  E18.5  embryos  and  (D)  P0  wildtype  and  Ctip2
-/-  mice. 
Amount of unsaturated ceramides was determined according to their N-
acyl chain length using LC/MS/MS analyses. Statistical analyses were 
performed by student’s unpaired t-test using Graphpad Prism software. 
*p<0.05. 
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Figure  2.3  LC/MS/MS  analyses  of  mouse  epidermal  saturated 
sphingomyelins during skin development.  
Epidermal  sphingolipids  were  extracted  from  skin  of  (A)  E16.5;  (B) 
E17.5;  (C)  E18.5  embryos  and  (D)  P0  wildtype  and  Ctip2
-/-  mice. 
Amount of saturated sphingomyelins was determined according to their 
N-acyl  chain  length  using  LC/MS/MS  analyses.  Statistical  analyses 
were  performed  by  student’s  unpaired  t-test  using  Graphpad  Prism 
software. *p<0.05; **p<0.005. 
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Figure  2.4  LC/MS/MS  analyses  of  mouse  epidermal  unsaturated 
sphingomyelins during skin development.  
Epidermal  sphingolipids  were  extracted  from  skin  of  (A)  E16.5;  (B) 
E17.5;  (C)  E18.5  embryos  and  (D)  P0  wildtype  and  Ctip2
-/-  mice. 
Amount  of  unsaturated  sphingomyelins  was  determined  according  to 
their N-acyl chain length using LC/MS/MS analyses. Statistical analyses 
were  performed  by  student’s  unpaired  t-test  using  Graphpad  Prism 
software. *p<0.05; **p<0.005; ***p<0.001. 
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Figure 2.5 LC/MS/MS analyses of mouse epidermal sphingosines 
and sphinganines during skin development.  
 
Epidermal sphingosines and sphinganines were measured in the skin of 
(A)  E16.5,  (B)  E17.5,  (C)  E18.5  embryos  and  (D)  P0  wildtype  and 
Ctip2
-/- mice. The amount of skin sphingosines and sphinganines were 
determined  according  to  their  N-acyl  chain  length  by  LC/MS/MS 
analyses, quantified utilizing sphingosine  and sphinganine standards,  
and  expressed  as  pmol/  mg    of  skin  (for  details  see  methods).  
Statistical analyses were performed by student’s unpaired t-test using 
Graphpad  Prism  software.  The  results  depicted  in  this  figure  are 
representative  of  at  least  two  additional  studies  that  have  been 
conducted using different litters of mice of identical genotypes. 
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Figure 2.6 UPLC/MS/MS analyses of mouse epidermal cholesterol 
and fatty acids during skin development.  
Epidermal  lipids  were  extracted  from  skin  of  E16.5,  E17.5,  E18.5 
embryos and P0 wildtype and Ctip2
-/- mice. Amount of (A) cholesterol, 
(B)  cholesterol  3-sulfate,  (C)  palmitic  acid  and  (D)  stearic  acid  were 
determined  using  UPLC/MS/MS  analyses.  Statistical  analyses  were 
performed by student’s unpaired t-test using Graphpad Prism software. 
*p<0.05; **p<0.005. 
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Figure 2.7 Ctip2 regulates the expression of genes encoding lipid 
metabolizing enzymes during skin development.  
Expression  of  (A,  B,  C)  ceramide  synthases  (Lass1-Lass3,  Lass6), 
serine  palmitoyltransferases  (Sptlc1,  Sptlc3);  (D,  E,  F) 
sphingomyeinases  (Smpd1,  Smpd2),  sphingomyelin  synthase  2 
(Sgms2), glucosylceramide synthase (Ugcg) and acid beta-glucosidase 
(Gba2);  (G,  H,  I)  N-acylsphingosine  amidohydrolases  (acid 
ceramidases: Asah1, Asah2), sphingosine kinases (Sphk1, Sphk2) and 
alkaline ceramidases (Acer1, Acer2) was analyzed by RT-qPCR using 
specific  primers  indicated  in  table  S1.  All  values  represent  relative 
transcript  level  after  normalization  with  Gapdh  transcripts. Statistical 
analyses were performed by student’s unpaired t-test using Graphpad 
Prism software. *p<0.05; **p<0.005. The results depicted in this figure 
are representative of at least three additional studies that have been 
conducted using numerous litters of mice of identical genotypes. 
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Figure  2.8  Relative  expression  of  genes  encoding  lipid-
metabolizing enzymes during skin development.  
Expression  of  ceramide  synthases  (Lass4-5),  serine 
palmitoyltransferase  2  (Sptlc2),  dihydroceramide  desaturase  (Degs1), 
Ketodihydro-sph  reductase  (Kdsr)  and  sphingomyelin  synthase  1 
(Sgms1) was studied at (A) E16.5, (B) E17.5 and (C) E18.5 stages of 
development by RT-qPCR using specific primers indicated in table S1. 
Values represent relative transcript level after normalization with Gapdh 
transcripts. Statistical analyses were performed by student’s unpaired t-
test using Graphpad Prism software. 
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Figure S3, Wang et al., 2012 
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Figure 2.9 Immunoblot analyses of lipid metabolizing enzymes in 
the developing murine epidermis.  
 
(A) Western blotting analyses was performed on protein extracted from 
E18.5 wildtype (WT) and Ctip2
-/- mice epidermis to study the expression 
level of eLox3, Gba2 and Lass2 using specific antibodies. β-actin was 
used  as  an  internal  control.  (B)  Protein  levels  of  eLox3,  Gba2  and 
Lass2  were  quantified  in  wildtype  and  mutant  epidermis  by 
densitometry analyses of western blots. All data was normalized by the 
corresponding  β-actin  levels.  Statistical  analyses  were  performed  by 
student’s unpaired t-test using Graphpad Prism software. *p<0.05. The 
results  depicted  in  this  figure  are  representative  of  at  least  three 
additional  studies  that  have  been  conducted  using  different  litters  of 
mice of identical genotypes. 
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Figure 2.10 Ctip2 interacts directly with the promoter region of 
lipid metabolizing genes.  
Chromatin immunoprecipitation (ChIP) assay was performed on freshly 
isolated  neonatal  mouse  skin  keratinocytes  using  anti-Ctip2  antibody 
and results were analyzed by qPCR using primers indicated in table S2. 
Rat IgG was used as a control. Ctip2 was recruited to the promoter 
regions of (A) Lass2, (B) Gba2 and (C) eLox3. Statistical analyses were 
performed by student’s unpaired t-test using Graphpad Prism software. 
*p<0.05; **p<0.005. 
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Figure  2.11  ChIP  analyses  on  murine  keratinocytes  for  lipid 
metabolizing genes.  
Chromatin immunoprecipitation (ChIP) assay was performed on freshly 
isolated  primary  keratinocytes  from  neonatal  mouse  skin  using  anti-
Ctip2  antibody  and  results  were  analyzed  by  qPCR  using  specific 
primers indicated in table S2. Rat IgG was used as a control. Ctip2 was 
not recruited to distal and proximal promoter regions of (A) Lass1, (B) 
Lass2, (C) Lass6, (D) Ugcg, (E) Smpd1, (F) Smpd2, (G) Smpd3, (H) 
Sgms2, (I) Elovl4, (J) Dgat2 and (K) Aloxe12b.  
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Figure  2.12  Schematic  representation  of  Ctip2  mediated 
differential regulation of genes encoding different  enzymes  of the 
ceramide synthesis pathways.  
 
The scheme indicates metabolic pathways for ceramide biosynthesis: 
de  novo  pathway,  salvage  pathway,  sphingomyelinase  pathway  and 
exogenous ceramide recycling. Genes involved in these pathways are 
indicated. Stages at which altered gene expression were observed are 
indicated  within  brackets.  Red:  downregulation  of  gene  expression; 
green: upregulation of gene expression. Ctip2 positively regulates Gba2 
and Lass2 expressions by direct recruitment to their promoter regions. 
Expression  of  ceramide  synthases  1-6  (Lass  1-6),  serine 
palmitoyltransferases  1-3    (Sptlc  1-3),  dihydroceramide  desaturase 
(Degs1), Ketodihydro-sph reductase (Kdsr), glucosylceramide synthase 
(Ugcg),  acid  beta-glucosidase  (Gba2),  sphingomyelin  synthases  1-2 
(Sgms1-2), sphingomyeinases 1-2 (Smpd1, Smpd2),N-acylsphingosine 
amidohydrolases  (acid  ceramidases:  Asah1,  Asah2),  alkaline 
ceramidases  1-2  (Acer1,  Acer2),  sphingosine  kinases  1-2    (Sphk1, 
Sphk2)   are  indicated   for the different  pathways.    
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Table 2.1 Primer sequences used in q-PCR assays.  
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Table 2.2 Primer sequences used in ChIP assays. 
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Ctip2  is  crucial  for  epidermal  homeostasis  and  protective  barrier 
formation in developing mouse embryos. Selective ablation of Ctip2 in 
mouse epidermis leads to increased transepidermal water loss  (TEWL) 
from skin, impaired epidermal proliferation and terminal differentiation 
as well as altered lipid composition during development. However, little 
is known about the role of Ctip2 in adult mice skin homeostasis. To 
study the role of Ctip2 in adult skin homeostasis, we utilized a Ctip2
ep-/- 
mouse  model  in  which  Ctip2  is  selectively  deleted  in  epidermal 
keratinocytes.  Measurement  of  TEWL,  followed  by  histological, 
immuno-histochemical and RT-qPCR analyses on skin biopsies from 
control and mutant mice revealed an important role of Ctip2 in barrier 
maintenance and in regulating adult skin homeostasis. We have shown 
that keratinocytic ablation of Ctip2 leads to atopic dermatitis (AD)-like 
skin inflammation, characterized by alopecia, pruritus and dermatitis, as 
well as high infiltration of T lymphocytes and immune cells. We have 
also  observed  increased  expression  of  Th2-type  cytokines  and 
chemokines in the mutant skin, as well as systemic immune responses 
that  share  similarity  with  human  AD  patients.  Furthermore,  we 
discovered  that  thymic  stromal  lymphopoietin  (TSLP)  expression  is 
significantly upregulated in the mutant epidermis as early as postnatal 
day 1 and Ctip2 was recruited to the promoter region of the TSLP gene  
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in epidermal keratinocytes.  The results suggest that upregulation of 
TSLP  expression  in  the  Ctip2
ep-/-  epidermis  could  be  due  to  a 
derepression of gene transcription in absence of Ctip2. Thus, our data 
demonstrated a cell-autonomous role of Ctip2 in barrier maintenance 
and  epidermal  homeostasis  in  adult  skin,  as  well  as  a  non-cell 
autonomous role of keratinocytic Ctip2 in suppressing skin inflammatory 
responses by regulating the expression of Th2-type cytokines in adult 
mouse skin.  Present results establish an initiating role of epidermal 
TSLP in AD pathogenesis via a novel repressive regulatory mechanism 
mediated by Ctip2. 
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3.2 Introduction 
 
Mammalian  skin  forms  the  first  defense  barrier  in  the  body  for 
protecting  against  physical  injuries,  ultraviolet  radiation,  bacterial 
infections as well as excessive loss of water (Fuchs and Raghavan, 
2002). The most abundant cell type in epidermis is keratinocytes, which 
forms four layers: basal, spinous, granular and stratum corneum (Fuchs 
and Raghavan, 2002; Proksch et al., 2008). Atopic dermatitis (AD) is a 
chronic, inflammatory disease of the skin that starts at early childhood. 
AD patients are genetically predisposes to the disease, which has a 
prevalence of 10%-20% in children and 1%-3% in adults (Leung and 
Bieber,  2003;  Tokura,  2010).  Clinical  features  of  AD  include  skin 
xerosis, pruritus and eczematoid skin lesions (Leung and Bieber, 2003). 
AD is characterized by both skin barrier deficiencies and immunological 
responses  (Scharschmidt  and  Segre,  2008).  In  atopic  dermatitis,  a 
defective skin barrier is thought to permit the penetration of allergens 
and  induces  the  interactions  of  the  allergens  with  immune  cells, 
promoting the subsequent release of pro-inflammatory cytokines and 
chemokines and elevation of IgE level (Cork et al., 2009). 
 
The molecular pathways involved in AD pathogenesis remain unclear. 
There  have  been  many  reports  on  the  connections  between  atopic  
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dermatitis and Th2 inflammatory pathways (Leung and Bieber, 2003; 
Biedermann  et  al.,  2004;  B.  Brandt  and  Sivaprasad,  2011).  Pro-Th2 
cytokines,  such  as  IL-4,  IL-13,  IL-5,  and  IL10,  are  elevated  in  AD 
patients (B. Brandt and Sivaprasad, 2011). One possible candidate that 
initiates inflammatory responses in AD is thymic stromal lymphopoietin 
(TSLP), which is a member of hematopoietic cytokine family and highly 
expressed in skin-derived epithelial cells, fibroblasts, and dendritic cells 
(Comeau and Ziegler, 2010; Ziegler, 2010; Kashyap et al., 2011). TSLP 
signals  through  a  heterodimeric  receptor  formed  by  TSLP  receptor 
(TSLPR) as well as IL-7 receptor alpha (IL7Ra) (Comeau and Ziegler, 
2010). TSLP is a key keratinocyte-derived cytokine, whose expression 
was greatly increased in the epidermis of a group of acute and chronic 
atopic dermatitis patients (Soumelis et al., 2002). Mice that are deficient 
of  nuclear  receptors  (NRs)  retinoid  X  receptor a  (RXRa),  vitamin  D 
receptor (VDR) or Notch1 in epidermal keratinocytes, exhibit epidermal 
permeability barrier (EPB) defects, express elevated levels of TSLP in 
skin,  and  subsequently  develop  AD-like  phenotypes  (Li,  2005,  2006; 
Demehri et al., 2008; Ziegler, 2010).  
 
Chicken ovalbumin upstream promoter transcription factor (COUP-TF) 
interacting protein 2 (Ctip2), also known as Bcl11b, is a C2H2 zinc finger  
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protein  that  is  crucial  in  the  development  of  central  nervous  and 
immune system (Avram et al., 2000; Arlotta et al., 2005; Topark-Ngarm 
et al., 2006; Kastner et al., 2010). Ctip2 is also expressed in human and 
mouse adult epidermis (Golonzhka et al., 2007; Ganguli-Indra et al., 
2009).  Studies  with  mice  harboring  germline  deletion  and  epidermal 
specific  ablation  of  Ctip2  revealed  its  critical  role(s)  in  epidermal 
proliferation  and  terminal  differentiation,  as  well  as  barrier  formation 
during  mouse  embryonic  development  in  both  cell  autonomous  and 
non-cell autonomous ways (Golonzhka et al., 2008). Ctip2 was shown 
to be a “master regulator” in skin homeostasis by interacting with the 
promoter regions of many genes involved in skin development such as 
eLox3, Gba2, Lass2 and Notch1 (Wang et al., 2012, submitted). Since 
Ctip2 null mice die at birth, the function(s) of keratinocytic Ctip2 in adult 
mice  EPB  maintenance  as  well  as  in  epidermal  homeostasis  is 
unknown.  
Here  we  report  a  novel  role  of  Ctip2  in  regulating  epidermal 
homeostasis  and  skin  inflammation  by  selective  Cre-recombinase 
mediated  ablation  of  Ctip2  gene  in  epidermal  keratinocytes  of  adult 
mice  skin  (Indra  et  al.,  1999;  Dassule  et  al.,  2000).  We  show  that 
ablation  of  Ctip2  in  adult  mice  epidermal  keratinocytes  results  in 
impaired  EPB  maintenance,  increased  epidermal  hyperplasia  and  a  
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severe form of AD-like skin inflammation that becomes disseminated 
with progression of the disease, all of which are very similar to AD in 
humans.  Our  present  data  indicates  that  keratinocytic  Ctip2  plays  a 
crucial role in triggering skin inflammatory responses by regulating the 
expression of genes encoding Th2-type cytokines in adult mouse skin.  
The results presented herein establish an initiating role of epidermal 
TSLP in AD pathogenesis and demonstrate a key anti-inflammatory role 
of Ctip2, which strongly represses TSLP expression in wild-type skin.  
 
3.3 Materials and Methods 
 
Mice 
The function of Ctip2 in adult mice skin homeostasis was characterized 
using  Ctip2
ep-/-  mice  that  selectively  lacked  Ctip2  in  epidermal 
keratinocytes after Cre-recombinase mediated deletion of Ctip2 gene in 
keratinocytes using K14-Cre deleter mice (Indra et al., 1999; Dassule et 
al., 2000; Golonzhka et al., 2008). Ctip2 floxed mice (Ctip2 
L2/L2, WT) 
were used as controls (Indra et al., 1999; Golonzhka et al., 2008). 8 to 
10  mice  from  multiple  litters  were  used  in  each  group  at  each  time 
point. Mice were maintained in a temperature/humidity-controlled facility  
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with a 12-hour light/dark cycle. OSU IACUC approval was obtained for 
animal experiments.  
 
Transepidermal water loss (TEWL) measurement 
Transepidermal  water  loss  was  measured  using  the  calibrated 
Tewameter  TM300  with  Multi  Probe  Adapter  (CK  electronic  GmbH, 
Köln, Germany) in accordance with manufacture operating instructions. 
Data was expressed in g/m
2h, and represents the mean ± S.E.M. for 8 
independent animals (8 measurements each animal) of each genotype. 
Statistical analysis was performed using Graphpad Prism software with 
student’s unpaired t-test. 
 
Histological analysis 
Skin  biopsies  were  fixed  in  4%  paraformaldehyde  overnight  and 
embedded  in  paraffin  blocks.  5mm  paraffin  sections  were  sectioned 
using a Leica RM2255 microtome (Bannockburn, IL). Hematoxylin and 
eosin staining was performed according to general protocols (Wang et 
al., 2011).  
Combined  eosinophil/mast  cell  stain  (C.E.M)  was  performed  using  a 
commercial  kit  according  to  the  manufacturer’s  protocol  (American 
MasterTech, Lodi, CA). Briefly, slides were deparaffinized with xylene  
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and  hydrated  through  alcohols.  After  washed  in  running  tap  water, 
slides were placed in astra blue staining solution for 30 minutes and 
rinsed in tap water. Slides were put in vital new red staining solution for 
another 30 minutes and rinsed with tap water. After that, slides were 
placed in modified Mayer’s hematoxylin for 15-30 seconds and rinsed 
again with tap water for 2 minutes. Finally, dehydration of slides was 
performed  with  3  changes  of  absolute  alcohol  and  xylene  before 
mounting. Mast cells showed bright blue color while eosinophils were 
red. Nuclei were stained blue.  
Toluidine  blue  staining  was  performed  as  described  (Li,  2005). 
Toluidine  blue  working  solution  was  prepared  by  mixing  5ml  1% 
toluidine blue EtOH solution (Sigma-Aldrich, St. Louis, MO) with 45ml 
1% sodium chloride (pH2.3). Slides were deparaffinized and hydrated in 
distilled  water.  Sections  were  stained  with  toluidine  blue  working 
solution  (pH2.0-2.5)  for  2-3  minutes  before  washed  in  3  changes  of 
distilled water. Slides were dehydrated through alcohols and xylenes 
and mounted with resinous mounting medium. 
 
Immunohistochemistry 
IHC staining of paraffin and frozen sections was described previously 
(Wang et al., 2011; Liang et al., 2012). In brief, paraffin sections were  
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deparaffinized and antigen retrieval was performed with pH6.0 citrate 
buffer  and  95-100°  C  for  20  minutes  and  cooled  down.  For  frozen 
sections,  slides  were  fixed  with  cold  acetone  for  20  minutes  and 
allowed for air dry. Slides were washed with 0.1% PBST and blocked 
with 10% normal goat serum (Vector Laboratories, Builingame, CA) for 
30 minutes before incubated with primary antibodies overnight at 4°C. 
Fluorescently labeled secondary antibodies were applied to slides for 
an hour at room temperature. Nuclei were visualized with DAPI. After 
the final washes, slides were dehydrated and mounted. Images were 
captured  at  X20  magnification  using  a  Carl  Zeiss  Axio  Imager  Z1 
fluorescent microscope and AxioCam camera. Data were analyzed and 
quantified using Adobe Photoshop and ImageJ software. Multiple IHC 
fields  were  randomly  chosen  and  10-15  such  fields  per  slide  were 
counted independently in a double-blinded manner. All experiments in 
each category were repeated in triplicates. 
The concentrations of antibodies used were as follows: Ki67 (Abcam, 
Cambridge, MA, 1:500), K14 (Abcam, 1:1000), K10 (Abcam, 1:1000), 
Filaggrin (Abcam, 1:1000), Loricrin (Abcam, 1:500), F4/80 (Biolegend, 
San Diego, CA, 1:250), CD11b (Abcam, 1:100), CD45 (Abcam, 1:500), 
Ly6g (Abcam, 1:250), CD11c (BD Pharmingen, San Jose, CA, 1:100), 
RXRα  (Santa  Cruz  Biotechnology,  Santa  Cruz,  CA,  1:1000),  Notch1  
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(Cell Signaling technology, Danvers, MA, 1:500), Cy3 goat anti rabbit 
(Jackson ImmunoResearch Laboratories Inc, West Grove, PA, 1:500), 
Cy3 goat anti rat (Jackson ImmunoResearch, 1:500), Cy2 goat anti rat 
(Jackson  ImmunoResearch,  1:500),  Cy3  goat  anti  mouse  (Jackson 
ImmunoResearch, 1:1000). 
 
RT-qPCR 
RNA  extraction  and  cDNA  preparation  were  performed  as  described 
(Indra et al., 2005b). Real-time PCR was performed on an ABI 7500 
Real-Time PCR system using SYBR Green methodology using specific 
sets  of  primers  as  indicated  in  Supplementary  Table1  (Indra  et  al., 
2005a, 2005b). Relative gene expression analysis of the RT-qPCR data 
was  performed  using  HPRT  as  an  internal  control.  All  assays  were 
performed in triplicates. 
 
ELISA 
ELISA  kits  for  detecting  mouse  IL-4,  IL-13,  TNFα  and  TSLP  were 
obtained  from  eBioscience,  Inc.  (San  Diego,  CA,  USA).  Mouse  IgE 
ELISA  kit  was  procured  from  Bethyl  Laboratories,  Inc.  (Montgomery, 
TX,  USA),  while  CCL17  immunoassay  kit  was  purchased  from  R&D 
Systems, Inc. (Minneapolis, MN, USA).  
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1-month and 4-month-old mice (6 WT and 6 Ctip2
ep-/- from each age 
group)  were  selected  for  studying  secondary  systemic  response  to 
Ctip2
ep-/- genotype. Blood plasma was isolated from the mice following 
the  method  of  Argmann  and  Auwerx  (Argmann  and  Auwerx,  2006). 
ELISA was performed for estimation of the levels of IL-4, IL-13, IgE, 
CCL17,  TNFα  and  TSLP  using  kits  following  the  respective 
manufacturer’s instructions. All samples were assayed in triplicates. 
 
Chromatin immunoprecipitation (ChIP) 
ChIP assay was performed according to Hyter et al., 2010 with minor 
modifications  (Hyter  et  al.,  2010).  Briefly,  mouse  epidermal 
keratinocytes from 1-day postnatal wildtype mice skin were isolated and 
fixed in 1% formaldehyde. Cell lysate from 3x10
6 keratinocytes (each 
ChIP)  were  obtained  after  incubation  with  hypotonic  buffer  (10mM 
Tris/HCl,  pH7.5,  10mM  NaCl,  3mM  MgCl2  and  0.5%  NP40).  Nuclei 
were  suspended  in  ChIP  sonication  buffer  (50mM  Hepes,  pH7.9, 
150mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% SDS, 0.1% sodium 
deoxycholate)  with  0.2%  SDS.  Nuclei  were  sonicated  and 
immunoprecipitated with 2mg anti-Ctip2 antibody (Abcam, Cambridge, 
MA)  overnight  at  4°C.  Rat  IgG  was  used  as  a  control.  25ml  pre-
equilibrated protein G beads (Invitrogen, Carlsbad, CA) were added to  
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each ChIP and incubated for four hours at 4°C. After washing twice with 
ChIP  sonication  buffer,  buffer  A  (50mM  Hepes,  500mM  NaCl,  1mM 
EDTA, 1% Triton X-100, 0.1% SDS and 0.1% sodium deoxycholate), 
buffer B (20mM Tris/HCl, pH8.0, 1mM EDTA, 250mM LiCl, 0.5% NP40 
and  0.5% sodium  deoxycholate)  and  once  with  TE  buffer,  DNA  was 
uncrosslinked  at  65°C  overnight  and  purified  by  QIAquick  PCR 
Purification Kit (Qiagen, Germantown, MD). All the buffers used in the 
study were added with PMSF and protease inhibitors before use. DNA 
was  amplified  using  ABI-7500  Real-time  PCR  machine  with  specific 
primers  indicated  in  Supplementary  Table  1.  Primers  were  designed 
from proximal (-200bp) and distal (-1kb) promoter regions of TSLP to 
study the possible interaction between Ctip2 and TSLP, and primers 
selected from 3’-UTR region was used as a control. 
 
Statistics 
Statistical  significance  of  differences  between  groups  was  analyzed 
using  GraphPad  Prism  software  using  student’s  unpaired  t-test.  All 
statistical analyses were performed in a double-blinded manner.    
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3.4 Results 
 
3.4.1 Selective ablation of Ctip2 in epidermal keratinocytes leads 
to altered epidermal proliferation, differentiation and spontaneous 
dermatitis in adult skin 
The function of Ctip2 in adult mice skin homeostasis was characterized 
using  Ctip2
ep-/-  mice  that  selectively  lacked  Ctip2  in  epidermal 
keratinocytes after Cre-recombinase mediated deletion of Ctip2 gene in 
keratinocytes using K14-Cre deleter mice (Indra et al., 1999; Dassule et 
al., 2000). At approximately 8-10 weeks after birth, 67% Ctip2
ep-/- mice 
(n=18)  developed  dry  and  scaly  skin  and  17%  mutant  mice  also 
developed spontaneous lesions on the dorsal skin at the same age, 
which were absent in wildtype (WT) mice (Fig 3.1 A). The severity of all 
of these abnormalities worsened with age (Figure 3.1 A). By 4 months 
of  age,  almost  all  the  mutants  (89%,  n=18)  developed  spontaneous 
dermatitis that occurred predominantly on the dorsal skin, in the neck 
region,  and  on  the  face  (Figure  3.1  A).  Furthermore,  progressive 
alopecia was evident in most of the 4 month-old Ctip2
ep-/- mice (~85%) 
(Figure 3.1 A). We hypothesized that the skin lesions observed in the 
mutant mice could be due to impaired function of the skin barrier. To 
test this hypothesis, trans-epidermal water loss (TEWL) was measured 
in wildtype and Ctip2
ep-/- mice. Interestingly, the mutant mice showed  
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increased TEWL as early as 2 weeks of age, and the values were ~10-
fold  higher  than  wildtype  mice  at  4  months  of  age  (Figure  3.1  B).  
Histological  analysis  of  hematoxylin-  and  eosin-  (H&E)  stained  skin 
sections revealed significant epidermal hyperplasia in Ctip2
ep-/- mice as 
early as 2 weeks of age (Figures 3.1 C and D).  
In order to determine if increased epidermal hyperplasia could be due 
to  altered  keratinocyte  proliferation,  immunohistochemical  (IHC) 
analyses  for  proliferation  marker  Ki67  and  keratin  14  (K14)  were 
performed  on  control  and  mutant  skin  (Figures  3.2  A  and  D).  The 
percentage  of  Ki67-positive  cells  was  significantly  higher  in  Ctip2
ep-/- 
epidermis  compared  to  the  wild-type  littermates  at  all  time-points 
(Figure  3.2  A  and  D).  Similarly,  the  expression  level  of  K14  in  the 
mutant epidermis was prominently increased in Ctip2
ep-/- mice at 2 and 
4  months  of  age  (Figure  3.2  B).  Expression  levels  of  the  early 
differentiation  marker  K10  were  not  significantly  different  between 
wildtype  and  Ctip2
ep-/-  mice  (Figure  3.2  C).  Expression  of  terminal 
differentiation markers, filaggrin and loricrin, were also upregulated in 
Ctip2
ep-/-  mice  at  later  time  points  (Figure  3.3  A-B).  These  results 
indicate  that  selective,  somatic  ablation  of  Ctip2  in  epidermal 
keratinocytes  leads  to  increased  epidermal  proliferation  and  altered 
terminal  differentiation  during  adulthood.  Altogether,  results  suggest  
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that  adult  Ctip2
ep-/-  mice  exhibited  impaired  barrier  functions  and 
developed spontaneous dermatitis, which worsened as the mice aged. 
 
 
3.4.2.  Increased infiltration of inflammatory cells in adult Ctip2
ep-/- 
mice skin 
Dermal  infiltrates  were  notable  in  Ctip2
ep-/-  mice  starting  around  2 
months  of  age,  as  revealed  by  histological  analyses  (Figure  3.1  C).  
Combined  eosinophil  and  mast  cell  (C.E.M.)  staining  revealed 
increased eosinophils in the dermis of Ctip2
ep-/- skin around 1 month of 
age, while mast cells were most numerous in the mutant dermis at 4 
months of age (Figures 3.4 A and B). IHC staining for T lymphocytes 
revealed a two-fold increase in CD3
+ T cells in the skin of 4 month-old 
Ctip2
ep-/-  mice  compared  to  the  wild-type  skin  (Figures  3.5  A-B).  A 
similar  increase  in  the  number  of  CD4
+  T  cells  was  observed  in  4 
month-old mutant skin compared to the wildtype skin (Figure 3.5 C and 
D).  The number of macrophages in the dermis was significantly higher 
in Ctip2
ep-/- mice skin at 4 months of age (Figure 3.6 A-B), as were the 
number of infiltrating neutrophils and monocytes (Figure 3.6 C-F). In 
addition, CD45
+ cell infiltration was observed in one month-old Ctip2
ep-/- 
mice  skin,  but  this  resolved  by  4  months  of  age  (Figure  3.6  G-H).   
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Taken together, these results demonstrate an increased inflammatory 
response in Ctip2
ep-/- skin that progressively increased with time.  
 
3.4.2 Preferential induction of Th2-type cytokines and chemokines 
in adult Ctip2
ep-/- skin 
Upregulated expression of cytokines and chemokines play a crucial role 
in  inflammatory  skin  diseases  (Grewe  et  al.,  1998;  B.  Brandt  and 
Sivaprasad, 2011). Differential expression profiles of cytokines and/or 
chemokines  orchestrate  and  determine  the  type  and  outcome  of 
inflammatory responses in mouse and human skin. We next determined 
if  expression  of  pro-inflammatory  cytokines/chemokines  were 
dysregulated in mutant skin. RT-qPCR analyses revealed a preferential 
induction of Th2-type cytokines, including TSLP, CCL17, IL13, IL4, IL6, 
and  IL10  in  mutant  skin  (Figures  3.7  A-E  and  3.10  A).  In  contrast, 
neither expression of Th1-type (IL1α, IL2, IL12a/b; Figure 3.10 B-E) nor 
that of Th17-type (IL17a, IL18 and IL23; Figure 3.10 F-H) cytokines was 
unaltered in mutant skin.  
Time course analyses also revealed several distinct induction patterns 
of  cytokines  and  chemokines  in  the  mutant  skin.  TSLP,  a  master 
initiator  of  Th2  inflammatory  responses,  was  induced  ~30-fold  at 
postnatal  day  1  (P1),  and  we  observed  a  ~200-fold  induction  at  P7  
 
   
101 
compared  to  control  skin  (Liu,  2006).  Expression  of  TSLP  remained 
significantly high at all later time points (~1000-fold induction between 1 
month to 4 months after birth; Figure 3.7 A). Interestingly, the high level 
of  TSLP  expression  was  observed  predominantly  in  the  mutant 
epidermis,  whereas  TSLP  transcripts  were  barely  detectable  in  the 
dermal layer of the mutant skin (Figure 3.7 F). These data suggest that 
TSLP  may  be  an  initial  triggering  cytokine  that  is  induced  in  the 
absence of Ctip2 in the epidermis.  
Chemokine  CCL17  is  one  of  known  downstream  genes  whose 
expression can be stimulated by TSLP (Ziegler and Artis, 2010). CCL17 
and  IL13  transcripts  were  significantly  induced  in  the  mutant  skin  at 
around 1 week and 2 weeks after birth, respectively. Induction of these 
two genes was transient, peaking at 1 month, followed by a decrease of 
expression during later time points (2 - 4 months; Figure 3.7 B and C). 
In  contrast  to  these  early  and  transient  inductions,  we  observed  a 
strong, late induction of cytokines IL4 and IL6 and chemokines CCL3 
and  CXCL2  in  the  mutant  skin  (Figure  3.7  D-E,  3.8  L-M).  We  also 
observed  a  late  onset  of  induction  of  Th1-type  cytokines,  including 
TNFα and IFNγ, at 4 months of age (Figure 3.8 N-O). These results 
suggest that deletion of Ctip2 in the epidermis leads to an increased  
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inflammatory  response,  which  is  characterized  by  a  Th2-type 
cytokine/chemokine profile. 
 
3.4.3 TSLP is a direct target of Ctip2 in epidermal keratinocytes 
Recent studies have revealed that ablation of RXRα and RXRβ in adult 
murine  keratinocytes  leads  to  an  AD-like  phenotype  triggered  by 
induction of TSLP (Li, 2005).. Similarly, TSLP is also elevated in Notch 
signaling-deficient  keratinocytes  (deficient  in  either  Notch1/2  or 
recombining  binding  protein  suppressor  of  hairless  (RBP-j;  Refs  (Li, 
2005; Demehri et al., 2008; Dumortier et al., 2010)). Thus, it is possible 
that Ctip2 regulates TSLP expression via the nuclear receptor or Notch 
signaling  pathways  in  epidermis.  To  test  that,  we  determined  the 
expression  of  key  players  in  both  the  Notch  and  RXR  signaling 
pathways,  including  Notch1,  Notch2,  RBP-j,  RXRα  and  RXRβ. 
Expression of the corresponding transcripts was not affected by loss of 
Ctip2 in the epidermis at both one and four months after birth (Figure 
3.12 A-D, data not shown). Similarly, epidermal protein levels of Notch1 
and RXRα were comparable between wildtype and mutants at all time-
points,  suggesting  an  alternative  mechanism  of  Ctip2-mediated 
regulation of TSLP expression in the adult murine skin (Figure 3.12 E-
F).   
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In  order  to  determine  if  Ctip2  directly  regulates  TSLP  expression  in 
murine  keratinocytes,  we  conducted  chromatin  immunoprecipitation 
(ChIP)  assays  on  neonatal  mouse  epidermal  extracts.  Primers  were 
designed from the proximal (-200bp) and distal (-1kb) promoter region 
relative  to  the  transcriptional  start  site  of  TSLP  to  determine  the 
possible  interaction  of  Ctip2  with  TSLP.  We  observed  that  Ctip2 
interacted with the distal but not the proximal region of TSLP promoter, 
suggesting  Ctip2  may  directly  repress  TSLP  transcription  in  mouse 
keratinocytes  (Figure  3.7  G).  Hence,  ablation  of  Ctip2  in  epidermal 
keratinocytes  could  lead  to  upregulation  of  TSLP  expression  due  a 
derepression mechanism.   
 
3.4.4 Systemic inflammatory responses in older Ctip2
ep-/- mice 
We hypothesized that chronic skin inflammation developed in Ctip2
ep-/-
 
mice may trigger systemic immune responses in the mutant skin. To 
test that we determined blood plasma concentrations of IgE as well as 
various Th2-type cytokines/chemokines (IL-4, IL-13, CCL17 and TSLP) 
and Th1-type cytokine TNF-α from 1-month and 4-months-old mice by 
ELISA (Figure 3.9 A-F). Plasma level for all of the tested cytokines, 
were observed to be higher in both 1-month and 4-month old mutant 
mice (Figure 3.9 A-E), including IL4 and the related IL-13 (Figure 3.9 A,  
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B), CCL17 (Figure 3.9 C), TSLP (Figure 3.9 D), and TNFα (Figure 3.9 
E).  While  circulating  IgE  levels  were  elevated  in  both  wild-type  and 
mutant mice at four months of age, IgE levels in mutant mice were 2.5 
times greater than those in wildtype mice (Figure 3.9 F). 
Ctip2
ep-/- mice exhibited inguinal lymphadenopathy smaller convoluted 
thymus at four months of age (Figure 3.10 A, data not shown).  The 
mutant  mice  displayed  progressive  splenomegaly  starting  from  one 
month of age, with a 2-fold increase in spleen weight at the age of four 
months (Figure 3.10 A-B). Histological studies of the spleens revealed 
an  increased  cell  infiltration  in  the  4-month-old  mutant  spleen  in 
comparison with wildtype (Figure 3.11 A, D, G, J). 4 month-old Ctip2
ep-/- 
mice exhibited increased eosinophil infiltration in the spleen and lymph 
node compared with wildtype (Figure 3.11, B, E, H, K). Very few mast 
cells were observed in both wildtype and mutant mice spleens and the 
number of mast cells was larger in the lymph node, indistinguishable 
between 4 month-old wildtype and mutant mice (Figure 3.11, C, F, I, L). 
These  results  clearly  indicate  that  Ctip2
ep-/-
 mice  display  a  systemic 
immune  response  that  may  be  driven  by  primarily  TSLP  expression 
from keratinocytes. 
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3.5 Discussion 
 
Epidermal keratinocytes have long been suspected to play a crucial role 
in  initiating  and  directing  the  immune  response  in  inflammatory  skin 
diseases, such as AD.  In the present report we have shown that skin of 
adult  Ctip2
ep-/-  mice,  with  an  epidermal-specific  deletion  of  the  gene 
encoding Ctip2, display histological and cellular features that are typical 
of human AD. First, Ctip2
ep-/- mice develop skin lesions, alopecia and 
pruritus, which are major clinical features in patients afflicted with AD 
(Leung and Bieber, 2003; Dubrac et al., 2010; Boguniewicz and Leung, 
2011).  Second,  Ctip2
ep-/-  mice  exhibit  epidermal  hyperplasia  that  is 
characterized by increased epidermal proliferation and differentiation, 
similar to what has been observed in AD patients (Proksch et al., 2008). 
Third,  the  skin  of  Ctip2
ep-/-  mice  is  characterized  by  a  dramatic 
upregulation of Th2-type cytokines and chemokines, including TSLP, 
CCL17, IL13 and IL4. TSLP, all of which were induced early in Ctip2
ep-/- 
epidermis, and are crucially involved in the initiation of pathogenesis in 
human AD (Tokura, 2010; B. Brandt and Sivaprasad, 2011; Novak and 
Leung,  2011).  Finally,  Ctip2
ep-/-  adult  mice  exhibit  Th2-like  systemic 
immune  syndrome  that  is  similar  to  that  found  in  most  AD  patients 
(Spergel, 2003). Based on the phenotypic spectrum of Ctip2
ep-/- adult  
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mice, it appears that this line may serve as a useful model for the study 
of human AD.  
Selective  ablation  of  Ctip2  in  the  developing  epidermis  reduced 
epidermal  proliferation  and  impaired  terminal  differentiation  of 
keratinocytes (Golonzhka et al., 2008). Isolated Ctip2 null keratinocytes 
also  exhibit  severe  proliferation  and  differentiation  defects  in  culture 
(Zhang et al., submitted). To our surprise, in the postnatal stages, the 
epidermis of Ctip2
ep-/- adult mice exhibited increased proliferation and 
differentiation  compared  with  wild-type  epidermis  (Figure  3.1  C,  3.2, 
3.3). A hyperplastic epidermis and a significantly higher percentage of 
Ki67-positive cells were observed in the mutants as early as 1 week 
after birth. Elevated proliferation and differentiation could be secondary 
to  impaired  epidermal  barrier  functions  caused  by  Ctip2  ablation. 
Previous  studies  have  established  that  hyperproliferation  and 
acanthosis  (thickened  epidermis)  are  compensatory  responses  to 
impaired epidermal barrier (Proksch et al., 1991) 
 
A number of candidate genes have been identified in association with 
AD, however, may of these linkages have been called into question due 
to  insufficiently  powered  studies  and/or  heterogeneity  of  the  disease 
(Dubrac et al., 2010; Boguniewicz and Leung, 2011). In independent  
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studies,  several  genes  such  as  Filaggrin  (FLG),  trans-acting  T-cell-
specific transcription factor (GATA3) and IL4 has been reported to be 
involved  in  AD  pathogenesis  (Barnes,  2010).  FLG  deficiency  alone 
decreases stratum corneum hydration and leads to increased TEWL, 
and  has  been  correlated  with  AD  in  the  highest  number  of  studies 
(Palmer  et  al.,  2006;  Barnes,  2010).  It  is  worth  mentioning  that  skin 
barrier deficiency has also been reported in AD patients without FLG 
mutation(s)  or  loss  of  expression  (Jakasa  et  al.,  2010)  suggesting 
existence  of different  subtypes of AD in humans. We have shown 
previously  that  Ctip2  deficiency  is  associated  with  impaired  terminal 
differentiation  and  decreased  FLG  expression  during  development 
(Golonzhka et al., 2008). Indeed, we have observed a ~50% reduction 
of FLG expression in the epidermis of Ctip2
ep-/- skin compared to that of 
wildtype littermates around 1 week of age (Figure 3.13). However, no 
significant difference in level of FLG expression was observed between 
the wildtype and mutant epidermis at later timpoints from 2 weeks to 4 
months of age possibly due to a compensatory upregulation of other 
related factors such as Ctip1 (Figure 3.3A, 3.13). The lack of loss-of-
FLG  expression  observed  in  Ctip2
ep-/-  mice  at  later  stages,  indicates 
possible involvement of other factors to modulate barrier integrity.   
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TSLP,  a  keratinocyte-derived  triad  of  cytokines,  has  been  studied 
intensively  recently  in  the  pathogenesis  of  allergic  inflammation  and 
subsequent development of AD and other immune disorder (Soumelis 
et al., 2002; Yoo, 2005; Liu, 2006). It is recognized as the master switch 
for AD and other atopic diseases, such as asthma, as it plays a critical 
role to induce the Th2-type allergic inflammation in AD pathogenesis 
(Liu, 2006). Keratinocyte-derived TSLP participates in the inflammatory 
cascade by activation of other immune cells, such as dendritic cells and 
mast  cells,  and  subsequent  stimulation  of  release  of  Th2-related 
cytokines/chemokines  from  these  immune  cells,  eventually  initiate 
inflammatory a Th2 lymphocyte response (Soumelis et al., 2002; Liu, 
2009;  Comeau  and  Ziegler,  2010).  In  the  present  study,  we  have 
observed that TSLP was the earliest known cytokine induced in Ctip2
ep-
/- mice and this induction was maintained in the mutants at all postnatal 
stages of development. Expression of CCL17, a downstream target of 
TSLP,  was  also  significantly  induced  in  the  mutant  mice  at  early 
timepoints.  The  induction  of  TSLP  was  mainly  restricted  to  the 
epidermis, which correlates well with epithelial cells of the keratinocyte 
lineage as major producers of TSLP in AD patients (Soumelis et al., 
2002).  Hence,  induction  of  TSLP  following  Ctip2  ablation  in  
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keratinocytes could be a trigger factor that initiates and directs the Th2-
type inflammatory cascade observed in Ctip2
ep-/- skin.  
Transgenic mice over-expressing TSLP in keratinocytes develop AD-
like symptoms, indicating that TSLP expression is sufficient to initiate 
AD-like  inflammatory  responses  (Yoo,  2005).  Therefore,  it  remains 
critical to address upstream triggers of TSLP expression and how TSLP 
is  regulated  before  and  during  AD  pathogenesis.  Transcriptional 
regulation of TSLP by transcription factors (NF-κB, AP-1, AP-2α) and 
nuclear receptors (RXR, RAR, VDR) were reported previously (Li, 2005, 
2006; Lee and Ziegler, 2007; Lee et al., 2008; Takai, 2012). NF-κB and 
AP-1 was shown to directly regulate TSLP expression by binding to -
3.8kb of transcription initiation site in mouse and human lung epithelium 
cells (Lee et al., 2008). Previous studies have identified presence of a 
RARE (DR2) around  ~ 1kb of the TSLP promoter region that may bind 
to  RXRα(β)-RAR  heterodimers  (Li,  2006).  Since  we  have  observed 
Ctip2  recruitment  around  that  region  on  the  mTSLP  promoter,  it  is 
possible that NRs and Ctip2 could be a part of the same transcriptional 
complex  to  regulate  TSLP  gene  expression  in  mouse  keratinocytes. 
However, additional co-recruitment of Ctip2 along with NRs in further 
distal region of the mTSLP gene promoter cannot be ruled out. Here, 
we have identified a novel transcriptional regulatory mechanism(s) of  
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negative regulation of TSLP expression by Ctip2 in mouse epidermis. 
Ctip2 appears to interact directly with and repress expression of the 
TSLP promoter.  
We have demonstrated a predominant upregulation of Th2 cytokines in 
the Ctip2
ep-/- skin at all timepoints, but a late surge of Th1 cytokines, 
including IFNγ and TNF α , was also observed in the mutant skin at 4 
months  (Figure 3.8 N-O). Indeed, it has been demonstrated that Th2- 
and  Th1  type  cytokines  both  contribute  to  different  stages  of  the 
development of skin lesions in AD patients (Grewe et al., 1998). Th2-
cell  subsets  are  specifically  activated  during  the  initiation  phase, 
followed  by  the  Th1-cell  subset  to  maintain  the  persistence  of  the 
chronic inflammatory response. Our work confirms that Th2- and Th1-
type immune responses are not mutually exclusive, especially at the 
chronic  phage  of  the  inflammatory  disease.  The  interaction  between 
different Th-cell subsets at the chronic stage may be a fruitful area for 
future investigation of AD pathogenesis.  
Systemic immune response related to elevated expression of IL-4, IL13, 
CCL17  and  IgE,  observed  in  Ctip2
ep-/-  mice  is  evidently  Th2  cell-
dependent  and  humoral  in  nature.  IL-4,  for  example,  induces 
differentiation  of  CD4
+  T-cells  into  Th2  cells,  and  also  inhibits 
production of Th1 cells (Rang, 2003). Th2 cells secrete IL-13, which  
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together with IL-4, initiates a B lymphocyte-directed, humoral response 
(Rang,  2003).  IL-4  also  upregulates  MHC  class  II  expression  and 
induces  B-cell  class  switching  to  IgE  [41,  42].  Furthermore,  TSLP 
stimulation  of  naïve  CD4
+  T-cells  induces  a  specialized  Th2 
polarization, which results in production of downstream Th2-associated 
pro-inflammatory  cytokines,  such  as  IL-13,  which  carry  out  humoral 
immune processes (Ziegler and Artis, 2010). Simultaneously, CCL17 is 
known  to  attract  Th2  cells,  thereby  favoring  humoral  responses 
(Nakayama  et  al.,  2004).  In  summary,  inflammation  due  to  selective 
Ctip2 ablation in mice epidermis is not restricted to the site of deletion; 
rather Ctip2
ep-/- mice show a chronic secondary Th2-dependent humoral 
systemic inflammatory response. 
In summary, our study reveals a novel role(s) of keratinocytic Ctip2 in 
epidermal barrier maintenance and homeostasis, and inflammation in 
adult mice. Ctip2 clearly modulates AD-like responses within the skin, 
as  well  as  systemic  inflammatory  responses.  TSLP  was  strongly 
induced  in  Ctip2
ep-/-  epidermis  and  likely  causes  increased  dendritic 
cells  infiltration  into  lymph  nodes,  in  which  these  cells  interact  with 
CD4
+ T cells to produce Th-2 inflammatory cytokines. Subsequently, 
other immune cells such as macrophages, leukocytes, mast cells and 
eosinophils  could  be  attracted  and  recruited  to  the  site  of  skin  
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inflammation,  which  become  disseminated,  leading  to  elevated 
circulating levels of inflammatory mediators. This study identifies a new 
mediator, Ctip2, that may be implicated in the etiology of AD.  However, 
several  issues  need  to  be  resolved  in  the  future.  For  example,  it  is 
presently unclear if a defective skin barrier precedes inflammation and 
enhanced cellular proliferation in the early stages of AD development.  
Second, the contributory role of TSLP in AD and the mechanistic basis 
of  regulation  of  TSLP  expression  in  keratinocytes  have  not  been 
identified. Finally, the role of Ctip1 in AD development in presence or 
absence  of  Ctip2  could  shed  further  lights  in  AD  pathogenesis  and 
identify new avenues for therapeutic intervention. Our study highlights a 
central  role  of  epidermal  keratinocytes  in  initiating  and  shaping  the 
immune response during the pathogenesis of AD-like skin diseases in 
mice.  
 
  
 
   
113 
 
   
0
10
20
30
40
2w         1m           2m          4m
*** ***
***
***
WT
Ctip2ep-/-
e
p
i
d
e
r
m
a
l
 
t
h
i
c
k
n
e
s
s
 
(
µ
m
) D  
 
   
114 
Figure  3.1  Ctip2
ep-/-  mice  develop  a  chronic  skin  lesions  and 
epidermal hyperplasia.  
(A)  Gross  morphology  of  4  months  old  wildtype  (WT)  and  Ctip2
ep-/- 
mice. The yellow arrowheads indicate lesion and alopecia of Ctip2
ep-/- 
mice  in  the  back,  face  and  neck,  to  be  compared  with  the  normal 
appearance in a wildtype mouse. (B) Measurement of trans-epidermal 
water loss (TEWL) from dorsal skin of wildtype and Ctip2
ep-/- mice at 
different time points. Statistical analyses were performed by student’s 
unpaired  t-test  using  GraphPad  Prism  software;  **  P<  0.01,  *** 
P<0.001. (C) Hemotoxylin & Eosin stained 5µm thick paraffin sections 
from dorsal skin of WT and Ctip2
ep-/- mice at 1 week (1W), 2 weeks 
(2w), 1month (1m), 2 months (2m) and 4 months (4m). Scale bar: 100 
µm. Epidermis (E) and dermis (D) are indicated. (D) Measurement of 
epidermal thickness of WT and Ctip2
ep-/- mice skin. Statistical analyses 
were  performed  by  student’s  unpaired  t-test  using  GraphPad  Prism 
software;  *  P<0.05,  **  P<  0.005,  ***  P<0.0001. 
 
   
115 
   
 
  
 
   
116 
Figure  3.2  Ctip2
ep-/-  mice  develop  enhanced  epidermal 
proliferation.  
Immunohistochemical  staining  of  dorsal  skin  biopsies  from  WT  and 
Ctip2
ep-/- mice was performed with antibodies directed against (A) Ki67, 
(B) K14 and (C) K10 (all in red). All sections were counterstained with 
DAPI  (blue).  Scale  bar:  100  µm.  Epidermis  (E)  and  dermis  (D)  are 
indicated.  (D)  Epidermal  percent  Ki67  positive  cells  in  dorsal  skin 
sections of WT and mutant mice. Statistical analyses were performed 
by student’s unpaired t-test using GraphPad Prism software; * P<0.05, 
** P< 0.005. 
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Figure 3.3 Ablation of Ctip2 leads to increased epidermal terminal 
differentiation. 
Immunohistochemical  staining  of  dorsal  skin  biopsies  from  WT  and 
Ctip2
ep-/-  mice  was  performed  with  antibodies  directed  against  (A) 
filaggrin and  (B)  loricrin (all in red). All sections were counterstained 
with DAPI (blue). Scale bar: 100 µm. Epidermis (E) and dermis (D) are 
indicated. 
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Figure 3.4 Enhanced eosinophil and mast cell infiltrates in dorsal 
skin of Ctip2
ep-/- adult mice. 
 (A) Combined eosinophil and mast cell (C.E.M) staining for eosinophils 
(pink) and mast cells (blue). Black arrows point to eosinophils. Scale 
bar: 50 µm. (B) Toluidine blue stained dorsal paraffin skin sections of 
WT and Ctip2
ep-/- mice. Mast cells stain intensive blue color. Scale bar: 
100 µm. 
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Figure 3.5 Characterization of inflammatory cell infiltrates in dorsal 
skin of WT and in Ctip2
ep-/- adult mice.  
(A) Immunohistochemical staining of dorsal skin biopsies from WT and 
Ctip2
ep-/-  mice  were  performed  with  specific  antibodies  against  CD3 
(red). Yellow arrowhead indicates dermal infiltrates of CD3+ cells. Scale 
bar:  100  µm.  (B)  Percent  CD3+  T  cells  at  2m  and  4m.  (C) 
Immunostaining of CD4+ T cells (red) in WT and mutant mice. Scale 
bar: 100 µm. (D) Percent CD4+ T cells at 2m and 4m. All sections were 
counterstained with DAPI (blue). Statistical analyses were performed by 
student’s unpaired t-test using GraphPad Prism software; ** P< 0.005.  
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Figure 3.6 Increased inflammatory cell infiltrate in Ctip2
ep-/- adult 
mice.  
(A) Immunohistochemical staining of dorsal skin biopsies from WT and 
Ctip2
ep-/- mice were performed with specific antibodies against F4/80 
(green) to detect macrophage/dendritic cells. (B) Percent F4/80 positive 
cells at 2m and 4m. (C) Immunostaining of neutrophils (green) using 
anti-Ly6g  antibody  in  WT  and  mutant  mice  skin.  (D)  Percent  Ly6g 
positive  cells  at  2m  and  4m.  (E)  Immunostaining  of 
monocytes/macrophages (green) with anti-CD11b antibody in WT and 
mutant mice skin. (F) Percent CD11b positive cells at 2m and 4m. (G) 
Immunohistochemical  staining  of  dorsal  skin  biopsies  with  antibody 
against CD45 (green). (H) Percent CD45 positive cells at 1m and 2m. 
All sections were counterstained with DAPI (blue). Scale bar (A, C, E 
and  G):  100  µm.  Statistical  analyses  were  performed  by  student’s 
unpaired t-test using GraphPad Prism software; ** P< 0.005. 
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Figure  3.7  Th2-dependent  cytokine  and  chemokine  expression 
levels in WT and Ctip2
ep-/- skin. 
(A-F)  Quantitative  RT-PCR  (RT-qPCR)  analyses  of  cytokines  and 
chemokines in the dorsal skin of 1day, 1 week, 2 weeks, 1month, 2 
months and 4 months old WT and mutant mice using specific primers 
as  indicated  in  Supplementary  Table1.  Relative  mRNA  expression 
levels of (A) TSLP, (B) CCL17, (C) IL13, (D) IL4, and (E) IL6 in Ctip2
ep-/- 
skin was compared to wildtype (WT) skin (set as 1.0). (F) RT-qPCR 
analyses of TSLP mRNA levels in separated epidermis and dermis from 
tail skin. All values represent relative transcript level after normalization 
with  HPRT  transcripts. (G)  Chromatin  immunoprecipitation  (ChIP) 
assay  was  performed  on  freshly  isolated  neonatal  mouse  skin 
keratinocytes using anti-Ctip2 antibody and results were analyzed by 
qPCR  using  primers  indicated  in  table  S1.  Rat  IgG was  used  as  a 
control.  Ctip2  was  recruited  to  the  distal  promoter  regions  of  TSLP. 
Statistical analyses were performed by student’s unpaired t-test using 
GraphPad Prism software; * P<0.05, ** P<0.01, *** P<0.001.  
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Figure 3.8 Relative expression levels of cytokines and chemokines 
in WT and Ctip2
ep-/- skin. 
The expression level of (A) IL10, (B) IL1α, (C) IL2, (D) IL12a, (E) IL12b, 
(F) IL17a, (G) IL18, (H) IL23, (I) CCL20, (J) CCL22, (K) CXCL10, (L) 
CCL3, (M) CXCL2, (N) IFNγ and (O) TNFα was studied with RT-qPCR 
in 1-month and 4-month-old wildtype and Ctip2
ep-/- dorsal skin. Values 
represent  relative  transcript  level  after  normalization  with  HPRT 
transcripts. Statistical analyses were performed by student’s unpaired t-
test using GraphPad Prism software; * P<0.05, ** P<0.01, *** P<0.001. 
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Figure 3.9 Systemic immunological abnormalities in Ctip2
ep-/- adult 
mice.  
Serum concentration of (A)  IL4, (B) IL13, (C) CCL17, (D) TSLP, (E) 
TNFα and (F) IgE was measured by ELISA. Statistical analyses were 
performed by student’s unpaired t-test using GraphPad Prism software; 
* P<0.05, ** P< 0.01, *** P<0.005  
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Figure  3.10  Ctip2
ep-/-  adult  mice  exhibited  systemic  immune 
responses.  
(A) Gross morphological comparison of spleen, lymph node (LN) and 
liver in 4-months-old WT and Ctip2
ep-/- mice. (B) Spleen weight of WT 
and  Ctip2
ep-/-  mice  at  different  months  of  age  is  indicated.  Statistical 
analyses were performed by student’s unpaired t-test using GraphPad 
Prism software; * P<0.05, ** P< 0.01, *** P<0.005   
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Figure  3.11  Immunological  abnormalities  of  spleen  and  lymph 
node in Ctip2
ep-/- adult mice.  
 
(A,  D)  Hemotoxylin & Eosin stained 5µm thick paraffin sections from 
spleen of WT and Ctip2
ep-/- mice at 4m. (B, C, E, F) C.E.M staining for 
eosinophils  (pink)  and  mast  cells  (blue)  in  4  month-old  mice  spleen 
sections.  (G,  J)  Hemotoxylin  &  Eosin  stained  5µm  thick  paraffin 
sections of WT and Ctip2
ep-/- mice lymph node at 4m. (H, I, K, L) C.E.M 
staining for eosinophils (pink) and mast cells (blue) in 4 month-old mice 
lymph  node.  Black  arrows  point  to  eosinophils.  Scale  bar:  50  µm 
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Figure 3.12 Relative expression levels of RXRa and genes involved 
in Notch signaling pathway.  
The  expression  level  of  (A)  Notch1,  (B)  Notch2,  (C)  Rbp-j  and  (D) 
RXRα was studied with RT-qPCR in 1-month and 4-month-old wildtype 
and Ctip2
ep-/- dorsal skin. Values represent relative transcript level after 
normalization  with  GAPDH  transcripts. Statistical  analyses  were 
performed by student’s unpaired t-test using GraphPad Prism software. 
(E) Immunohistochemical staining of dorsal skin biopsies with antibody 
against  Notch1  (red)  and  (F)  RXRα (red).  Scale  bar:  100  µm.  All 
sections (in E & F) were counterstained with DAPI (blue).  
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Figure 3.13 Relative expression levels of FLG in 1w and 2w mice 
epidermis and dermis. 
The expression of FLG in (A) 1-week-old and (B) 2-week-old wildtype 
and  Ctip2
ep-/-  skin  by  RT-qPCR.  Values  represent  relative  transcript 
level  after  normalization  with  HPRT  transcripts. Statistical  analyses 
were  performed  by  student’s  unpaired  t-test  using  GraphPad  Prism 
software; * P<0.05, ** P<0.01, *** P<0.001. 
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Table 3.1 List of primers used for RT-qPCR and ChIP assays 
 
Gene  Sense  Antisense 
CCL3  CTCCCAGCCAGGTGTCATTTT  CTTGGACCCAGGTCTCTTTGG 
CCL11  TCCACAGCGCTTCTATTCCT  CTATGGCTTTCAGGGTGCAT 
CCL17  TACCATGAGGTCACTTCAGATGC  GCACTCTCGGCCTACATTGG 
CCL20  TCACCTCTGCAGCCAGGCAGA  TCTTAGGCTGAGGAGGTTCACAGC 
CCL22  CCGTCACCCTCTGCCATCACG  GACCTGCCTGGGATCGGCAC 
CXCL10  CCACGTGTTGAGATCATTGCCACG  ATCCATCGCAGCACCGGGGT 
CXCL2  AGAAGTCATAGCCACTCTCAAGGGC  AGCAGCCCAGGCTCCTCCTTT 
HPRT  GTTAAGCAGTACAGCCCCAAA  AGGGCATATCCAACAACAAACTT 
IL1a  TCACCTTCAAGGAGAGCCG  ATCTGGGTTGGATGGTCTCTT 
IL2  TGAGCAGGATGGAGAATTACAGG  GTCCAAGTTCATCTTCTAGGCAC 
IL4  GAGCCATATCCACGGATGCGAC  ATGCGAAGCACCTTGGAAGCCC 
IL5  CAGCTGTCCGCTCACCGAGCT  TTTCCACAGTACCCCCACGGACAG 
IL6  ACAAAGCCAGAGTCCTTCAGAGAGA  AGCCACTCCTTCTGTGACTCCAG 
IL10  GGCGCTGTCATCGATTTCTCCCC  GGCCTTGTAGACACCTTGGTCTTGG 
IL12a  CTGTGCCTTGGTAGCATCTATG  GCAGAGTCTCGCCATTATGATTC 
IL12b  AGTGTGAAGCACCAAATTACTCC  CCCGAGAGTCAGGGGAACT 
IL13  TGCTTGCCTTGGTGGTCTCGC  GCGGCCAGGTCCACACTCCA 
IL17a  ACGCGCAAACATGAGTCCAGGG  TGAGGGATGATCGCTGCTGCCT 
IL18  GTGAACCCCAGACCAGACTG  CCTGGAACACGTTTCTGAAAGA 
IL23a  GAACGCACATGCACCAGCGG  TGCAAGCAGAACTGGCTGTTGTCC 
TNFa  ACTTCGGGGTGATCGGTCCCC  TGGTTTGCTACGACGTGGGCTAC 
TSLP  ACGGATGGGGCTAACTTACAA  AGTCCTCGATTTGCTCGAACT 
RXRa  GATATCAAGCCGCCACTAGG  TGTTGTCTCGGCAGGTGTAG 
RXRb  CACCTCTTACCCCTTCAGCA  GAGCGACACTGTGGAGTTGA 
Notch1  TCAATGCCGTGGATGACCTA  CCTTGTTGGCTCCGTTCTTC 
Notch2  GAGAAAAACCGCTGTCAGAATGG  GGTGGAGTATTGGCAGTCCTC 
Rbpj  AGTTGCACAGAAGTCTTACGG  CCTATTCCAATAAACGCACAGGG 
TSLP-ChIP 
proximal 
ATCTTAACCCAACCCACCAT  CTAGGGGAGGAACAGCTTCT 
TSLP-ChIP 
distal 
CCGTAGGCGTTTAGGTGTTA  CAAAGACTGTGCTCGGGTAT 
TSLP-ChIP 
3’-UTR 
TATTGCAAATCCAGCTGTCA  TTTCCAAAAGTGCTCACAAAA 
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Skin, the largest body organ, provides both a physical and a chemical 
barrier against the outside world (Proksch et al., 2006, 2008; Segre, 
2006). The protective skin barrier is a very complicated system formed 
by a large number of inter-related components including proteins and 
lipids  (Fuchs  and  Raghavan,  2002).  The  alteration  of  any  of  these 
components results in altered barrier function(s), which can lead to mild 
to lethal phenotype. Therefore, altered skin barrier function is a central 
event  in  various  skin  diseases  (Segre,  2006).  Our  study  revealed  a 
novel  role  of  transcription  factor  Ctip2  in  skin  barrier  formation, 
maintenance and homeostasis.  
 
The establishment of an effective physical barrier protecting the living 
organism  from  its  surrounding  environment  is  the  key  function  of 
mammalian skin (Hoffjan and Stemmler, 2007). Most of the transport of 
substances across the stratum corneum (SC) takes place through the 
lipid  bilayer,  suggesting  its  essential  role  for  the  barrier  function 
(Jungersted et al., 2008). The major SC lipids, ceramides, cholesterol 
and  fatty  acids  have  distinct  roles  in  maintaining  normal  barrier 
functions (Elias and Menon, 1991; Ishikawa et al., 2010). Ceramides as 
well  as  cholesterol  were  shown  to  have  an  influence  on  (and  are 
influenced by) the integrity of the SC, while free fatty acids play a major  
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role in the lipid bilayer formation and pH maintenance (Baroni et al., 
2012). We have recently identified Ctip2 as a key regulator of skin lipid 
metabolism,  which  plays  an  important  role  in  establishment  of 
epidermal permeability barrier (EPB). Compared with wildtype, uneven 
and thinner distribution of neutral lipids was observed in the Ctip2 null 
mice at E17.5 (Golonzhka et al., 2008). Furthermore, the ultrastructural 
analyses of the epidermis have revealed defects in lipid disc formation, 
loosely  packed  corneocytes,  as  well  as  disorganized  intercellular 
lamellar body membranes in Ctip2 null mice (Golonzhka et al., 2008). 
Ablation of Ctip2 leads to altered lipid composition in the developing 
mouse epidermis by modulating the expression levels of key enzymes 
involved  in  lipid  metabolism.  We  also  demonstrated  that  Ctip2  was 
recruited  to  the  promoter  regions  of  several  genes  involved  in  the 
ceramide  biosynthesis  pathways  and  could  directly  regulate  their 
expression. 
 
Besides stratum corneum, other important components contribute the 
formation  of  physical  barrier,  such  as  the  nucleated  epidermis,  in 
particular  the  cell–cell  junctions  and  associated  cytoskeletal  proteins 
(Proksch  et  al.,  2008).  Ctip2  null  mice  skin  has  fewer  corneocytes, 
which  are  smaller,  more  fragile  and  less  resistant  to  sonication  
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compared to wildtype skin. The linkage of Ctip2 to reduced expression 
of  serine  proteases  such  as  channel-activating  serine  protease  1 
(Cap1) and kallikrein-related peptidase (Klk5, Klk7 and Klk14) as well 
as tight junction proteins (Occludin, tight junction protein 1 and 2) in 
skin barrier deficiency remains to be addressed (Furuse et al., 2002; 
Segre, 2003; Leyvraz et al., 2005; Hachem et al., 2006).  
 
In  addition  to  the  physical  barrier,  the  integrity  of  the  skin  is  also 
maintained by the human immune system, which is equipped with a 
variety  of  tools  that  contribute  to  the  establishment  of  an  efficient 
defense  system  against  various  challenges  including  pathogenic 
infections.  The  immune  defense  system  is  composed  of  humoral 
(antibody  mediated)  and  cellular  (T-cell  mediated)  constituents 
(Proksch et al., 2008; Baroni et al., 2012). The wide range of invading 
microorganisms  is  fended  by  several  immunological  facets,  including 
immediate,  nonspecific  mechanisms  (innate  immunity),  and  delayed, 
stimulus-specific responses (adaptive immunity) (Elias, 2007; Jung and 
Stingl, 2008; De Benedetto et al., 2012).  
 
Our  data  demonstrated  an  important  role  of  Ctip2  in  skin  immune 
defense system. We demonstrated that keratinocytic ablation of Ctip2  
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leads to atopic dermatitis (AD)-like skin inflammation, characterized by 
alopecia,  pruritus  and  scaling,  as  well  as  extensive  infiltration  of  T 
lymphocytes  and  immune  cells.  We  also  observed  increased 
expression of T-helper 2 (Th2)-type cytokines and chemokines in the 
mutant  skin,  as  well  as  systemic  immune  responses  that  share 
similarity  with  human  AD  patients.  Furthermore,  we  discovered  that 
TSLP expression was significantly upregulated in the mutant epidermis 
as early as postnatal day 1 and ChIP assay revealed that TSLP is likely 
a  direct  transcriptional  target  of  Ctip2  in  epidermal  keratinocytes.  
These  results  suggest  that  upregulation  of  TSLP  expression  in  the 
Ctip2
ep-/- epidermis could be due to a derepression of gene transcription 
in absence of Ctip2. 
 
Besides  these  diverse  strategies,  the  skin  provides  a 
chemical/biochemical  defense  system,  mainly  composed  of 
antimicrobial  peptides  (AMPs),  also  named  host  defense  peptides, 
which  kill  a  wide  spectrum  of  bacteria,  viruses  and  fungi,  and  some 
transformed or cancerous cells (Braff et al., 2005; Lai and Gallo, 2009; 
Borkowski  and  Gallo,  2011).  AMPs  build  up  an  innate  epithelial 
chemical shield with a rapid and direct first-line defense system termed 
as the anti-microbial barrier. AMPs have the ability to enhance immunity  
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by  modulating  the  inflammatory  response  and  activating  cellular  and 
adaptive  immunity  (Schauber  and  Gallo,  2009;  Gallo  and  Nakatsuji, 
2011).  Reduced  expression  of  AMPs  such  as  cathelicidin  and  β-
defensin has been observed in Ctip2 null skin epidermis at embryonic 
stage  E18.5  (unpublished  data),  indicating  potential  role  of  Ctip2  in 
mediating  formation  of  skin  chemical/  anti-microbial  barrier.  The 
molecular  mechanisms  underlying  Ctip2  mediated  regulation  of  AMP 
expression need to be identified.  
 
Thus,  Ctip2  could  be  involved  in  a  diverse  range  of  events  in  skin 
barrier formation, maintenance and homeostasis. Our study suggests 
that  Ctip2  is  a  bi-functional  transcription  regulator  that  can  either 
activate  or  repress  gene  expression  in  a  cell  and  context  specific 
manner.  During  sphingolipid  biosynthesis,  Ctip2  activate  the 
transcription  of  Lass2  and  Gba2  genes  by  binding  to  their  promoter 
regions; however, in the fulfillment of immunological barrier functions, 
keratinocytic  Ctip2  repress  the  expression  of  TSLP  gene  in  a  direct 
pattern by interacting with TSLP’s promoter region. The roles of Ctip2 in 
other  aspects  of  skin  function  such  as  hair  cycling  and  cancer 
pathogenesis are currently being pursued by Indra group.  
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Ctip1  and  Ctip2  are  highly  related  proteins  which  both  interact  to 
COUP-TF  family  members  and  have  similar  sequence-specific  DNA 
binding activities, it is highly possible that they have some overlapping 
functions in vivo (Avram et al., 2000, 2002). Ctip1 has been identified 
as a myeloid or B cell proto-oncogene in mouse and human, and it’s 
required for the normal lymphoid development as well as human fatal 
hemoglobin expression ( Nakamura et al., 2000; Satterwhite, 2001; Uda 
et al., 2008; Liu et al., 2003; Sankaran et al., 2008). We have shown 
that the severity of the epidermal barrier defects in Ctip2 null mice is 
reduced at later timepoints of development (E18.5 compared to E17.5), 
which  could  be  due  to  the  compensatory  mechanisms  mediated  by 
Ctip1 (Golonzhka et al., 2008). A modest increase of Ctip1 expression 
was observed in Ctip2 null mice at E18.5; however, the role of Ctip1 in 
epidermal  barrier  development  and  maintenance  is  still  unclear 
(Golonzhka  et  al.,  2008).  Future  investigation  about  the  expression 
pattern  and  distribution  of  Ctip1  in  mouse  epidermis  during 
development, as well as its role in cutaneous barrier formation will be 
performed utilizing Ctip1-null mice. 
 
In conclusion, our data suggested the critical role of Ctip2 in regulating 
epidermal  permeability  barrier  formation  and  maintenance.  On  one  
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hand, in embryonic mouse skin, Ctip2 is required for the establishment 
of  functional  epidermal  barrier  by  controlling  epidermal  lipid 
biosynthesis  and  metabolism,  keratinocyte  proliferation  and 
differentiation, as well as the formation of structurally intact components 
of skin barrier such as lipid discs, cornified envelopes, and intercellular 
lamellar  bodies.  On  the  other  hand,  Ctip2  is  crucial  in  adult  mice 
epidermal  barrier  homeostasis.  Loss  of  keratinocytic  Ctip2  leads  to 
dysregulated skin barrier characterized with AD-like phenotypes, such 
as epidermal hyperproliferation, immune cell infiltration, Th2-type skin 
inflammation, as well as systemic immunological syndrome.  This study 
identifies  a  new  mediator,  Ctip2,  transcriptionally  regulating  mouse 
epidermal barrier formation and homeostasis in both cell-autonomous 
and non cell-autonomous manner.     
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